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‘HISTORY’ OF MEDICINE
‘I have an earache:
2000 B.C. - Here eat this root.
1000 A.D. - That root is heathen. Here, say this prayer.
1850 A.D. - That prayer is superstition. Here, drink this potion.
1940 A.D. - That potion is snake oil. Here, swallow this pill.
1985 A.D. - That pill is ineffective. Here, take this antibiotic.
2000 A.D. - That antibiotic is artificial. Here, eat this root.”
- Author Unknown
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ABSTRACT
An increasing number of studies show that nutritional antioxidants such as vitamin E and
polyphenols are capable of blocking neuronal death in vitro and may have therapeutic
properties in animal models of neurodegenerative diseases including Alzheimer’s and
Parkinson’s diseases. In the present study, the neuroprotective ability of one such
polyphenolic antioxidant, curcumin, was investigated. Curcumin is the yellow curry spice
derived from turmeric, and is widely used as a dietary component and herbal medicine in
India.
Most neurological disorders are postulated to have an oxidative or excitototoxic basis.
Thus the effects of curcumin on oxidative stress in the rat brain were investigated.
Curcumin, administered to the rat in vivo and in vitro, was able to exert protective effects
on oxidative damage in the brain, induced by cyanide, a mitochondrial inhibitor.
Curcumin also offered protection against quinolinic acid induced lipid peroxidation, and
this protection was extended to lipid peroxidation induced by metals such as lead and
cadmium in the rat brain. Experiments conducted on the pineal gland revealed an
increased production of the neuroprotective hormone melatonin in presence of curcumin
in vivo.
The hippocampus is functionally related to vital behaviour and intellectual activities and
is known to be a primary target for neuronal degeneration in the brains of patients with
Alzheimer’s disease. Histological studies were undertaken to assess the effects of
iv
curcumin on lead induced toxicity on the rat hippocampus, the results of which show that
curcumin affords significant protection to the hippocampus of the lead treated rats.
This study also sought to elucidate possible mechanisms by which curcumin exerts its
neuroprotective capabilities. Curcumin was found to inhibit the action of cyanide on the
mitochondrial electron transport chain, one of the most common sources of free radicals.
Electrochemical, UV/VIS and Infrared spectroscopy were used to characterise
interactions between curcumin and the metals lead, cadmium, iron (II) and iron (III).
Curcumin was shown to directly chelate these metals with the formation and isolation of
two new curcumin complexes with lead, and one complex each with cadmium and iron
(III). These results suggest chelation of toxic metals as a mechanism of neuroprotection
afforded by curcumin.
The need for neuroprotective agents is urgent considering the rapid rise in the elderly
population and the proportionate increase in neurological disorders. The findings of this
study indicate that curcumin, a well-established dietary antioxidant, is capable of playing
a bigger role in neuroprotection, which needs to be further explored and exploited.
vTABLE OF CONTENTS
Title Page i
Dedication ii
Abstract iii
Table of Contents v
List of Figures xvi
List of Abbreviations xix
Acknowledgements xxii
CHAPTER ONE LITERATURE REVIEW
1.1 AN INTRODUCTION TO NEUROSCIENCE 1
1.2 THE BRAIN 1
1.2.1 Neuroanatomy 1
1.2.2 The limbic system 3
1.2.3 The hippocampus 4
1.3 MECHANISMS OF NEURODEGENERATION 6
1.3.1 Free Radicals and Oxidative Stress 6
1.3.1.1. Superoxide 7
1.3.1.2. Nitric Oxide 7
1.3.1.3. Peroxynitrate 8
1.3.1.4. Hydroperoxyl Radical 8
1.3.1.5. Hydroxyl Radical 9
1.3.1.6. Lipid Peroxidation 9
vi
1.3.1.6.1. Mechanism of Lipid Peroxidation 10
1.3.2 Excitotoxicity 11
1.3.3 The Role of the Mitochondria in Oxidative Stress
And Excitotoxicity 13
1.3.4 Neurotoxins 15
1.3.4.1 Quinolinic Acid 15
1.3.4.2 Cyanide 16
1.3.4.3 Metals 16
          1.3.4.3.1 Iron 17
         1.3.4.3.2 Lead 18
1.3.4.3.3 Cadmium 19
1.4 NEURODEGENERATIVE DISORDERS 20
1.4.1 Ageing 21
1.4.2 Alzheimer’s Disease 22
1.4.3 Parkinson’s Disease 23
1.5 MECHANISMS OF NEUROPROTECTION 24
1.5.1 Defences Against Free Radicals 24
1.5.2 Melatonin 26
1.6 PHYTOCHEMICALS 28
vii
1.6.1 Biological Activities Influenced by Phytochemials 29
1.6.1.1 Phytochemicals as Antioxidants 29
1.6.1.2 Phytochemicals as Modulators of Key Enzymes in
Biological Pathways 29
1.6.1.3 Phytochemicals as Anti-inflammatory Agents 30
1.6.2 Flavonoids 31
1.6.3 Turmeric 32
1.6.4 Curcumin 33
1.6.4.1 Chemistry 33
1.6.4.2 Biological Activities 34
1.6.4.3 Biotransformations of Curcumin 36
                                               1.6.4.3.1 Chemical Degradation 36
1.6.4.3.2 Biotransformation of Curcumin
in Mice 37
1.7 OBJECTIVES OF THIS STUDY 38
CHAPTER TWO SUPEROXIDE RADICAL GENERATION
2.1 INTRODUCTION 39
2.2 EFFECT OF POTASSIUM CYANIDE ON SUPEROXIDE
RADICAL GENERATION IN RAT BRAIN HOMOGENATE 42
2.2.1 Introduction 42
viii
2.2.2 Materials and Methods 42
2.2.2.1 Animals 42
2.2.2.2 Chemicals and Reagents 43
2.2.2.3 Preparation of the Brain Homogenate 43
2.2.2.4 Preparation of Standard Curve 43
2.2.2.5 Nitroblue Tetrazolium Assay 43
2.2.3 Results 44
2.2.4 Discussion 44
2.3 EFFECT OF CURCUMIN ON CYANIDE INDUCED
SUPEROXIDE RADICAL GENERATION IN RAT BRAIN
HOMOGENATE 46
2.3.1 Introduction 46
2.3.2 Materials and Methods 46
2.3.2.1 In vitro Exposure of Rat Brain to Curcumin 46
2.3.2.2 In vivo Administration of Curcumin 46
2.3.3 Results 47
2.3.4 Discussion 48
CHAPTER THREE BIOLOGICAL OXIDATION ASSAY
3.1 INTRODUCTION 50
3.2 EFFECT OF CYANIDE ON BRAIN  MITOCHONDRIAL
RESPIRATORY FUNCTION 51
ix
3.2.1 Introduction 51
3.2.2 Materials and Methods 51
3.2.2.1 Animals 51
3.2.2.2 Chemicals and Reagents 51
3.2.2.3 Isolation of Mitochondria from Rat Brain Homogenate 51
3.2.2.4 Biological Oxidation Assay 52
3.2.3 Results 52
3.2.4 Discussion 54
3.3 EFFECT OF CURCUMIN ON CYANIDE INDUCED IMPAIRMENT
OF BRAIN MITOCHONDRIAL RESPIRATORY FUNCTION 56
3.3.1 Introduction 56
3.3.2 Materials and Methods 56
3.3.2.1 Animals 56
3.3.2.2 Chemicals and Reagents 56
3.3.2.3 Isolation of Mitochondria from Rat Brain Homogenate 56
3.3.2.4 Biological Oxidation Assay 56
3.3.3 Results 57
3.3.4 Discussion 59
CHAPTER FOUR LIPID PEROXIDATION
4.1 INTRODUCTION 61
4.1.1 Analysis of Lipid Peroxidation by Thiobarbituric Acid Assay 61
x4.2 EFFECT OF QUINOLINIC ACID ON LIPID PEROXIDATION IN
RAT BRAIN HOMOGENATE 63
4.2.1 Introduction 63
4.2.2 Materials and Methods 63
4.2.2.1 Animals 63
4.2.2.2 Chemicals and Reagents 63
4.2.2.3 Preparation of the Brain Homogenate 63
       4.2.2.4 Preparation of Standard Curve 64
4.2.2.5 The TBA Assay 64
4.2.3 Results 64
4.2.4 Discussion 65
4.3 EFFECT OF CURCUMIN ON QUINOLINIC ACID INDUCED LIPID
 PEROXIDATION IN RAT BRAIN HOMOGENATE 67
4.3.1 Introduction 67
4.3.2 Materials and Methods 67
4.3.2.1 In vitro Exposure of Rat Brain to Curcumin 67
4.3.2.2 In vivo Administration of Curcumin 67
4.3.3 Results 68
4.3.4 Discussion 69
4.4 EFFECT OF TOXIC METALS, CADMIUM AND LEAD, ON LIPID
PEROXIDATION IN RAT BRAIN HOMOGENATE 72
xi
4.4.1 Introduction 72
4.4.2 Materials and Methods 72
4.4.3 Results 72
4.4.4 Discussion 74
4.5 EFFECT OF CURCUMIN ON CADMIUM AND LEAD INDUCED
LIPID PEROXIDATION IN RAT BRAIN HOMOGENATE 76
4.5.1 Introduction 76
4.5.2 Materials and Methods 76
4.5.3 Results 76
4.5.4 Discussion 78
CHAPTER FIVE HISTOLOGICAL ANALYSIS
5.1 INTRODUCTION 79
5.2 HISTOLOGICAL ANALYSIS OF THE EFFECTS OF LEAD ON THE
HIPPOCAMPUS 82
5.2.1 Introduction 82
5.2.2 Materials and Methods 82
5.2.2.1 Animals 82
5.2.2.2 Chemicals and Reagents 82
xii
5.2.2.3 Histological Techniques 83
5.2.2.3.1 Fixation of the Brain 83
5.2.2.3.2 Tissue Processing 83
5.2.2.3.3 Blocking Out 83
5.2.2.3.4 Sectioning 84
5.2.2.3.5 Transferring Sections to Slides 84
5.2.2.3.6 Staining 84
5.2.2.3.7 Mounting of Slides 85
5.2.2.3.8 Photo – Microscopy 86
5.2.3 Results 86
5.2.4 Discussion 87
5.3 HISTOLOGICAL ANALYSIS OF THE EFFECT OF
CURCUMIN ON LEAD – INDUCED STRUCTURAL
DAMAGE TO THE HIPPOCAMPUS 90
5.3.1 Introduction 90
5.3.2 Materials and Methods 90
5.3.2.1 Animals 90
5.3.2.2 Chemicals and Reagents 90
5.3.2.3 Histological Techniques 91
5.3.3 Results 91
5.3.4 Discussion 92
xiii
CHAPTER SIX ELECTROCHEMICAL ANALYSIS
6.1 INTRODUCTION 93
6.1.1 Cyclic Voltammetry 95
6.1.2 Adsorptive Stripping Voltammetry 96
6.2 MATERIALS AND METHODS 98
6.2.1 Chemicals and Reagents 98
6.2.2 Apparatus 98
6.2.3 Technique 99
6.2.3.1 Cyclic Voltammetry 99
6.2.3.2 Adsorptive Stripping Voltammetry 99
6.3 RESULTS 99
6.3.1 Curcumin 99
6.3.2 Curcumin and Lead 101
6.3.3 Curcumin and Cadmium 102
6.3.4 Curcumin and Iron (II) 103
6.3.5 Curcumin and Iron (III) 104
6.4 DISCUSSION 105
CHAPTER SEVEN METAL BINDING STUDIES: A
SPECTROSCOPIC STUDY
7.1 INTRODUCTION 107
xiv
7.2 MATERIALS AND METHODS 108
7.2.1 Chemicals and Reagents 108
7.2.2 UV/VIS Spectroscopy 108
7.2.3 Infrared Spectroscopy 108
7.3 RESULTS 109
7.3.1 UV/VIS Spectroscopy 109
7.3.2 Infrared Spectroscopy 113
7.4 DISCUSSION 114
CHAPTER EIGHT ORGAN CULTURE STUDIES:
THE EFFECT OF CURCUMIN ON
RAT PINEAL INDOLE METABOLISM
8.1 INTRODUCTION 117
8.1.1 Synthesis of Serotonin 117
8.1.2 Conversion of Serotonin to its Metabolites 119
8.2 MATERIALS AND METHODS 120
8.2.1 Animals 120
8.2.2 Chemicals and Reagents 120
8.2.3 Organ Culture of the Pineal Glands 123
8.2.4 Seperation of Indoles by Thin Layer Chromatography 123
xv
8.3 RESULTS 124
8.4 DISCUSSION 125
CHAPTER NINE GENERAL CONCLUSIONS AND
RECOMMENDATIONS FOR
FUTURE STUDIES   128
REFERENCES   133
APPENDICES   153
xvi
LIST OF FIGURES & TABLES
Figure 1.1 The main features of the brain depicted within its three main structural
classifications
Figure 1.2 Diagram of the afferent and efferent connections of the limbic system.
LMA: Limbic midbrain area
Figure 1.3 A depiction of a rat brain with hippocampus, fornix and mammillary
bodies highlighted in mauve tones, and showing the septal and temporal
poles of the hippocampus
Figure 1.4 Mechanism of lipid peroxidation
Figure 1.5 The mitochondrion: a major source of cellular free radicals
Figure 1.6 Removal of oxygen and nitrogen free radicals and other reactive species in
mammalian cells
Figure 1.7 Melatonin: a scavenger of both the OH. and H2O2 as shown above, with
the resulting products being cyclic 3-hydroxymelatonin and N1-acetyl-N2-
formyl-5-methoxy-kynuramine, respectively
Figure 1.8 Modulation of key enzymes in the arachidonic acid cascade by
phytochemicals
Figure 1.9 Fresh rhizomes of turmeric
Figure 1.10 Structural representation of the three curcuminoids
Figure 1.11 Chemical degradation of curcumin in aqueous solution
Figure 2.1 Schematic diagram illustrating the major subunits of the electron transport
chain and sites of O2.- production.
Figure 2.2 Concentration-dependent effect of KCN on superoxide generation in
whole rat brain homogenate
Figure 2.3 The effect of curcumin on KCN (1mM)-induced superoxide anion
generation on whole rat brain homogenate
Figure 2.4 The effect of increasing concentrations of KCN on superoxide generation
in rat brain homogenate obtained from rats pretreated with curcumin
30mg/kg i.p. for three consecutive days
Figure 3.1 The in vitro effect of cyanide (1mM) on brain mitochondrial ETC utilising
L-Malate as the substrate, after 0 minutes of incubation time.
Figure 3.2 The in vitro effect of cyanide (1mM) on brain mitochondrial electron
transport , using L-Malate as the substrate, after 30 minutes of incubation
time
Figure 3.3 The in vitro effect of cyanide (1mM) on brain mitochondrial electron
transport using L-Malate as the substrate, after 60 minutes of incubation
time
Figure 3.4 A comparison of the in vitro effect of curcumin (1mM) alone and in
                        presence of cyanide (1mM) to that of cyanide (1mM) alone and
                        control, on the brain mitochondrial ETC using L-Malate
                        as the substrate, after 0 minutes of incubation
Figure 3.5 A comparison of the in vitro effect of curcumin (1mM) alone, in
                        presence of cyanide (1mM), cyanide (1mM) alone and
                        control, on the brain mitochondrial electron transport using L-Malate
xvii
                        as the substrate, after 30 minutes of incubation
Figure 3.6 A comparison of the in vitro effect of curcumin (1mM) alone and in
                        presence of cyanide (1mM) to that of cyanide (1mM) alone and
                        control, on the brain mitochondrial electron transport using L-Malate
                        as the substrate, after 60 minutes of incubation
Figure 4.1 Concentration dependent effect of quinolinic acid on lipid peroxidation in
whole rat brain homogenate
Figure 4.2 The effect of curcumin (in vitro administration) on
QA (1mM)-induced lipid peroxidation in whole rat brain homogenate
Figure 4.3 The effect of increasing concentrations of QA on MDA levels in rat brain
homogenate obtained from rats treated with 30mg/kg curcumin (i.p.)
Figure 4.4 H-atom donation of curcumin to a bis-allylic radical (e.g. the linoleic acid
radical
Figure 4.5 Diagramatic representation of the antioxidant action of curcumin within
the cell membrane
Figure 4.6 The effect of increasing concentrations of cadmium chloride on MDA
production in rat brain homogenate
Figure 4.7 The effect of 0.01mM lead acetate on MDA production in rat brain
homogenate
Figure 4.8 The effect of increasing concentrations of curcumin on MDA produced by
0.1mM cadmium in rat brain homogenate
Figure 4.9 The effect of 0.01mM curcumin on MDA produced by equal
concentrations of lead in rat brain homogenate
Figure 5.1 The basic structural features of a neuron
Figure 5.2 A high power magnified section of nervous tissue showing large star
shaped neuronal cell body and the nerve cell processes
Figure 5.3 A Nissl-stained coronal section of the caudal telecephalon of a rat brain
showing the hippocampus
Figure 5.4 Cells of the CA1 region of the hippocampus from an animal of the control
group
Figure 5.5 Cells of the CA3 region of the hippocampus from an animal of the control
group
Figure 5.6 Cells of the CA1 region of the hippocampus from an animal treated with
lead acetate (20mg/kg i.p.) for seven days
Figure 5.7 Cells of the CA3 region of the hippocampus from an animal treated with
lead acetate (20mg/kg i.p.) for seven days
Figure 5.8 Cells of the CA1 region of the hippocampus from an animal treated with
lead acetate (20mg/kg i.p.) and curcumin (30mg/kg i.p.) for seven days
Figure 5.9 Cells of the CA3 region of the hippocampus from an animal treated with
lead acetate (20mg/kg i.p.) and curcumin (30mg/kg i.p.) for seven days
Figure 6.1 Most dynamic electrochemistry utilises the classic three-electrode system
as shown here
Figure 6.2 A typical cyclic voltammogram
Figure 6.3 A diagramatic representation of the adsorptive stripping voltammetric
technique, showing the accumulation, deposition and stripping steps
Figure 6.4 Adsorptive stripping voltammogram of curcumin in pH 4 buffer
xviii
Figure 6.5 Cyclic voltammogram of curcumin in pH 4 buffer
Figure 6.6 Adsorptive stripping voltammogram of lead in pH 4 buffer, and
lead in presence of increasing concentrations of curcumin
Figure 6.7 Adsorptive stripping voltammogram of lead alone and in presence of 1.3 x
10-4M curcumin showing a peak at –1.09V as well as the formation of a
new peak (*)
Figure 6.8 Adsorptive stripping voltammogram of cadmium alone (a) and in presence
of increasing concentrations of curcumin (b,c and d) with the  formation of
a new peak at 10 x 10 -5M curcumin (*).
Figure 6.9 Adsorptive stripping voltammogram of Fe2+ alone (a) and in presence of
increasing concentrations of curcumin.
Figure 6.10 Adsorptive stripping voltammogram of Fe3+ alone (a) and in presence of
increasing concentrations of curcumin (b and c) with a new peak
formation at 6 x 10-5M curcumin (*)
Figure 7.1 Spectroscopic analysis of curcumin and Fe3+ (3 x 10-5 M)
Figure 7.2 Spectroscopic analysis of curcumin and Fe3+ (7.8 x 10-6 M)
Figure 7.3 Spectroscopic analysis of curcumin and Fe2+ (3 x 10-5 M)
Figure 7.4 Spectroscopic analysis of curcumin and Fe2+ (7.8 x 10-6 M)
Figure 7.5 Spectroscopic analysis of curcumin and lead (3 x 10-5 M)
Figure 7.6 Spectroscopic analysis of curcumin and lead (7.8 x 10-6 M)
Figure 7.7 Spectroscopic analysis of curcumin and cadmium (3 x 10-5 M)
Figure 7.8 Spectroscopic analysis of curcumin and cadmium (7.8 x 10-6 M)
Figure 7.9 The development of absorption shoulders of curcumin at concentrations
higher than 3 x 10-5 M, and the collapsing thereof into a single peak upon
addition of metal (Fe3+)
Figure 7.10 Four forms of metal interaction known for the β-diketo moiety
Figure 8.1 Pineal indole metabolism
Figure 8.2 An illustration of the bi-dimensional thin layer chromatogram of the pineal
indole metabolites showing the direction in which the plate was run and
the location of the pineal indole metabolites
Figure 8.3 The effect of curcumin on pineal indole metabolism
Table 8.1 Composition of BGJb culture medium
xix
LIST OF ABBREVIATIONS
µA Microamperes
µg Microgram
µl Microlitre
µM Micromolar
0C Degree Celsius
5-HIAA 5-Hydroxyindole acetic acid
5-HT Serotonin
A Amperes
AD Alzheimer’s disease
AFMK N1-acetyl-N2-formyl-5-methoxykynuramine
Ag Silver
AgCl Silver chloride
aHT N-acetylserotonin
AIF Apoptosis inducing factor
aMT Melatonin
ANOVA One way analysis of variance
APP Amyloid precursor protein
ASV Adsorptive stripping voltammetry
ATP Adenosine triphosphate
Aβ β-amyloid
BBB Blood brain barrier
BHT Butylated hydroxytoluene
CA1 Cornu Ammonis 1
CA2 Cornu Ammonis 2
CAT Catalase
Ca2+ Calcium (II)
CA3 Cornu Ammonis 3
CA4 Cornu Ammonis 4
Camp Cyclic adenosine mono phosphate
Cd2+ Cadmium (II)
cm-1 Per centimetre
CNS Central nervous system
COX Cyclooxygenase
CPM Counts per minute
CSF Cerebrospinal fluid
CuZnSOD Copper-Zinc – catalysed Superoxide dismutase
CV Cyclic voltammetry
DMBA 7,12-dimethylbenz(a)anthracene
DNA Deoxyribonucleic acid
DPI 2,6-Diclorophenol-indophenol
e- Electron
EAA Excitatory amino acid
xx
EDTA Ethylenediaminetetraacetic acid
ETC Electron transport chain
Fe2+ Iron (II)
Fe3+ Iron (III)
g Grams
GABA Gamma-aminobutyric acid
GCE Glassy carbon electrode
GSH Reduced form of glutathione
H Hydrogen
H2O2 Hydrogen peroxide
HA 5-Hydroxyindole acetic acid
HIOMT Hydroxyindole – O – methyl transferase
HL 5-Hydroxytryptophol
HO.2 Hydroperoxyl radical
i.p. Intraperitoneal
ipa Anodic peak current
ipc Cathodic peak current
IR Infrared
KCl Potassium chloride
KCN Potassium cyanide
Kf Rate constant for forward reaction
Kr Rate constant for reverse reaction
LMA Limbic midbrain area
LOO. Lipid peroxyl radical
LOOH Lipid hydroperoxide
LOX Lipoxygenase
LTP Long term potentiation
M Molar
MA 5-Methoxyindole acetic acid
MAO Monoamine oxidase
MDA Malondialdehyde
mg Milligram
mg/kg Milligram per kilogram
ML 5-Methoxytryptophol
ml millilitre
mM Millimole
MnSOD Manganese – catalysed Superoxide dismutase
MPP+ 1-Methyl-4-phenyl-pyridinium ion
MPTP 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
mRNA Messenger ribonucleic acid
mV Millivolts
n Sample size
NA Noradrenaline
Na+ Sodium
NaCl Sodium chloride
NAD Nicotinamide adenine dinucleotide
xxi
NADPH Nicotinamide adenine dinucleotide phosphate
NaOH Sodium hydroxide
NAT N-Acetyltransferase
NBD Nitroblue diformazan
NBT Nitroblue tetrazolium
NE Norepinephrine
nm Nanometre
NMDA N-methyl-D-aspartate
NO Nitric oxide
NOS Nitric oxide synthase
NSAID Nonsteroidal anti-inflammatory drugs
O2 Oxygen
O2-. Superoxide radical
OH. Hydroxyl radical
ONOO- Peroxynitrate
PARS Poly-ADP ribose polymerase
Pb2+ Lead (II)
PBS Phosphate buffered saline
PD Parkinson’s disease
PhK phosphorylase-kinase
PTP Permeability transition pore
PUFA Polyunsaturated fatty acid
QA Quinolinic acid
RNA Ribonucleic acid
RNS Reactive nitrogen species
ROO. Peroxyl Radical
ROOH Hydroperoxyl Radical
ROS Reactive oxygen species
rpm Revolutions per minute
s Seconds
SD Standard deviation
SEM Standard error of mean
SOD Superoxide dismutase
SP Senile plaques
T Transmission
TBA 2-Thiobarbituric acid
TBA-MDA Thiobarbituric acid – Malondialdehyde
TCA Trichloroacetic acid
TLC Thin layer chromatography
TPA tetradecanoylphorbol-13-acetate
UK United Kingdom
USA United States of America
UV Ultraviolet
UV/VIS Ultraviolet/Visible
V Volts
v/v Volume by volume
xxii
ACKNOWLEDGEMENTS
I would like to thank the following people for their contributions toward this thesis:
My supervisor, Professor Santy Daya for giving me the opportunity to be part of his
research group. I am grateful for his guidance and supervision throughout the course.
Dr. Janice Limson, for the interest and enthusiasm she took in my work, which led to
novel ideas and fruitful research. Furthermore I would also like to thank her for her help
with the electrochemical part of this study and for her skillful editing of this thesis.
Dr. Bharathi Avula for inspiration, friendship, support and good advice.
Dr. Gary Watkins for his interest in my work and for lending his invaluable time and
expertise in inorganic chemistry to this study.
The staff of the department of pharmacy and my lab mates for the warmth and
cooperation extended towards me. Sally and Dave Morley for their competence in
providing a well-organised work environment, as well as for their support and friendship.
I also thank Leon Purdon for his kindness and willingness in assisting me whenever
needed.
My friends, Jasmine, Anitha and Rubina for companionship and encouragement; Ami for
his kind and enthusiastic help with many of my experiments, for proof-reading this thesis,
and for his infectious cheer and encouragement; Nishal, for being “so sweet” and caring;
Linda Emslie and Jeanette Coupe for always being ready to lend a listening ear or a
helping hand; Linda Heideman for being the perfect “neuromum”; and all my dear
friends at Lilian Britten House for understanding, encouraging and supporting me.
My parents for their unconditional love and support, and my sister, Shija, who has been a
source of strength and friendship to me always.
The National Research Foundation for financial assistance towards this study.
Above all, I give thanks to God for opening doors for me, for His provision and care and
for making all things possible.
1CHAPTER ONE
LITERATURE REVIEW
1.1 AN INTRODUCTION TO NEUROSCIENCE
Two hundred years ago the brain was thought by our forefathers to consist of a
concoction of spirits, which might be pure and tranquil, or even riotous and evil! The
discovery that the central nervous system consists of an immense universe of highly
complex units has been a slow and gradual one. In recent decades the brain and its
mechanisms have become the focal point of much interest and research, and indeed many
important and life changing discoveries and contributions have been made in the field of
neuroscience.
The continued and increased growth of older population age groups in many countries,
irrespective of whether they fall under the “developed” or “developing” status, is possibly
one of the main driving forces fuelling neuroscience and the study of neurodegenerative
diseases particularly Alzheimer’s disease, as well as age-related dementias in general.
This is also a reflection of the growing appreciation of the enormous consequences of
such disorders in terms of public health costs and shattered lives of the afflicted
individuals and their families. The result is a virtual explosion in the understanding of
how the brain functions, both at a cellular as well as molecular level.
1.2 THE BRAIN
1.2.1 NEUROANATOMY
The most common method of dividing the brain is into hindbrain, midbrain and forebrain
as shown in fig. 1.1.
 The hindbrain has three parts with functions in homeostasis, movement coordination,
and signal conduction. These include the medulla oblongata, cerebellum and the pons.
2The medulla oblongata and the pons are the lowest parts of the brain and appear as
swellings at the top of the spinal cord (Campbell, 1990).
FIG. 1.1 The main features of the brain depicted within its three main structural
classifications (http://www.educarer.com/brain.htm).
The medulla contains centres that perform various homeostatic and autonomic functions
such as breathing, heart and blood vessel activity, swallowing and digestion. The pons
also takes part in some of these activities such as regulating the breathing centres in the
medulla. All the sensory and motor neurons which pass to and from higher brain regions
pass through the hindbrain, making conduction of information one of the most important
functions of the medulla and pons.
The cerebellum is attached to the brain stem by peduncles. Its primary function is the
coordination of movement. This highly convoluted outgrowth on the dorsal surface of the
hindbrain is tucked behind and partially beneath the cerebrum (Campbell, 1990). The
3midbrain attaches the forebrain to the brain stem and it contains centres for the receipt
and integration of several types of sensory information. The most prominent areas of the
midbrain are two elevations known as the inferior and superior colliculi, which form part
of the visual and auditory systems (Nauta & Feirtag, 1979).
The largest enlargement of the neuroaxis is the forebrain, which is attached to the
brainstem by the midbrain and is the site where the most sophisticated neural processing
in the brain occurs (Seminars in Neurosciences, 1993). It is divided into the lower
diencephalon, which consists of two integrating areas, the thalamus and the
hypothalamus, and the upper telencephalon, which comprises the cerebrum.
Most of the neural input to the cerebral cortex is relayed by neurons with cell bodies in
the thalamus. It contains different nuclei that project information to specific anatomical
areas of the cerebrum. The hypothalamus is one of the most important sites for regulation
of homeostasis and is the source of the posterior pituitary hormones and the releasing
factors for the anterior pituitary. It also regulates hunger, thirst and sexual response
functions (Campbell, 1990).
The surface of the cerebral hemispheres, the largest and most complex part of the brain,
is deeply folded into hemispheres, lobes and gyri. Such folds allow for a large area of
cerebral cortex to be accommodated within the cranium. The longitudinal or saggital
fissure divides the cerebrum into left and right hemispheres, which extend as far as the
corpus callosum, white matter linking the two hemispheres of the cerebrum together
(Seminars in Neurosciences, 1993). The cerebral hemisphere incorporates the
hippocampus, the neocortex and the olfactory fields. Within the hemispheres are the
amygdala and corpus striatum. The corpus striatum comprises the globus pallidus and the
striatum, which includes the caudate nucleus and putamen (Nauta & Feirtag, 1979).
1.2.2 THE LIMBIC SYSTEM
The limbic system comprises the olfactory areas, hippocampus, amygdala, the septum,
cingulate cortex, and regulates the hypothalamic area. Fig. 1.2 shows a general picture of
4the limbic system. The significance of the limbic system lies in the role it plays in
emotion, motivation and memory (Butler, 1993).
FIG. 1.2 Diagram of the afferent and efferent connections of the limbic system.
LMA: Limbic midbrain area (Banniser, 1992).
1.2.3 THE HIPPOCAMPUS
The hippocampus is the most medial portion of the cerebral cortex and is developed from
the stalk of the original cerebral vesicle (Smythies, 1970). Named for the seahorse shape,
the hippocampus is the main relay station that determines whether a new memory should
go into long-term storage or be deleted after its short-term usefulness is over.
The hippocampal formation is a bi-lateral limbic structure, which resembles two “C’s”
that lean together at the top and spread apart at the base. The top portion is known as the
“dorsal hippocampus”, and because of its proximity to the septum, the dorsal tip of the
hippocampus is called the “septal pole” and the bottom tip is called the “temporal pole”
as shown in Fig. 1.3 (Amaral & Witter,1989).
5FIG. 1.3 A depiction of a rat brain with hippocampus, fornix and mammillary
bodies highlighted in mauve tones, and showing the septal and temporal
poles of the hippocampus (Amaral & Witter, 1989).
The internal structure of the hippocampus is the same throughout its length, and consists
of an infolded convolution of the evolutionarily older and simpler archicortex or
allocortex. A cross-section taken perpendicular to the long axis (septal-temporal) will
reveal the internal structure as two interlocking "Cs", one reversed in relation to the other,
each with its own principle cell layer. One "C" makes up Ammon's Horn or Cornu
Ammonis (CA1-CA3), also known as the "Hippocampus proper".
The principle cell layer of Ammon's Horn is the stratum pyramidale, or the pyramidal
cell layer. The other "C" is made up of the dentate gyrus, of which the stratum
granulosm, or granule cell layer is the principle cell layer. Although the dentate gyrus is
commonly included as part of the hippocampus, it is cytoarchitectonically distinct from
the hippocampus proper (Amaral, 1978; Bayer, 1985; Amaral & Witter, 1989).
However, the hilus of the dentate gyrus, the area inside the C created by the granule cells
is sometimes referred to as CA4. The hilar region is referred to as CA4 because the
pyramidal cell layer of the CA1-CA3 regions begins to break down as a tightly packed
 
6cell layer and becomes more spread out and sparse in this region, such that early
neuroanatomists did not distinguish between these areas.
The intrinsic connections between the principle cell layers of the dentate gyrus and CA
regions of the hippocampus are very clear. The hippocampus, when cut transverse to its
longitudinal (septal-temporal) axis, exhibits a strong afferent set of three connected
pathways known as the "trisynaptic" circuit or loop (Swanson, 1978). The second and
third layers, which are referred to as the “surface layers” of the entorhinal cortex, project
to the granule cells of the dentate gyrus through the perforant-path. The granule cells of
the dentate gyrus then project to the large pyramidal cells of CA3 region via the mossy
fibers system. Finally, the CA3 pyramidal cells project to the pyramidal cells of the CA1
subfield, via the Schaffer collateral system (Lorente de No, 1934; Blackstad, 1956;
Amaral, 1978).
The hippocampus is a primary target for neuronal degeneration in the brains of patients
with Alzheimer’s disease (Behl et al., 1997).
1.3 MECHANISMS OF NEURODEGENERATION
1.3.1           FREE RADICALS AND OXIDATIVE STRESS
By definition, a free radical is a molecule or atom that possesses an unpaired electron in
its outer orbit. They are generally unstable and very reactive. Free radicals are known to
play critical roles in many biochemical reactions that maintain normal cell functions.
Oxygen radicals are known to exert critical actions such as signal transduction, gene
transcription and regulation of soluble guanylate cyclase activity in cells (Zheng & Storz,
2000). However, as oxidants and inhibitors of enzymes containing an iron- sulfur center,
free radicals and other reactive species cause the oxidation of biomolecules, leading to
cell injury and death (McCord, 2000). Thus, free radicals demonstrate two “faces” in
biology, in that they serve as signalling and regulatory molecules at physiologic levels
7and highly deleterious and cytotoxic oxidants at pathologic levels (Freidovich, 1999).
Any free radical involving oxygen can be referred to as reactive oxygen species (ROS).
1.3.1.1 Superoxide
When molecular oxygen accepts an electron from a reducing agent, the primary product
generated is the superoxide anion (O2-). The superoxide anion and its conjugate acid, the
hydroperoxyl radical (HO
.
2) has been shown to be reactive to a number of compounds in
vitro. Superoxide oxidises alpha-tocopherol to 8-alpha-tocopherone, which spontaneously
forms alpha-tocopherol quinone (Nishikimi et al., 1980). The reduction of cytochrome c
by xanthine and xanthine oxidase is mediated by the superoxide anion (McCord &
Fridovich, 1968) and this reduction is used as the basis of assays for both O2- and
superoxide dismutase (SOD). The SOD enzymes are catalysts that have evolved a surface
charge arrangement to facilitate the specific use of O2- as a substrate (Benovic et al.,
1983).
The superoxide free radical has come to occupy an amazingly central role in a wide
variety of diseases. The toxicity of superoxide is seen in its ability to inhibit certain
enzymes and thereby attenuate vital metabolic pathways, as well as in its effects on other
major classes of biological molecules (McCord, 2000). E. coli deficient in SOD activity
show increased rates of mutagenesis (Touati  & Farr, 1990), illustrating the role of the
radical, directly or indirectly, in DNA alterations. In conditions of ischaemia and
reperfusion, the most acute problem resulting from the overproduction of superoxide
appears to be greatly increased rates of lipid peroxidation. Here the superoxide radical
plays paradoxical roles, in that it can both initiate and terminate lipid peroxidation chains
(Nelson et al., 1994).
1.3.1.2 Nitric Oxide
Nitric oxide (NO) is a free radical released by several cell types, especially vascular
endothelial cells and phagocytes (Moncada et al., 1991). Within the nervous system, NO
is responsible for relaxation of the pyloric sphincter in the gastrointestinal tract (Yun et
8al., 1996), mediation of penile erections (Melis et al., 1994) and vasodilation (Holscher,
1997). Nitric oxide has been suggested to be involved in both the normal functioning of
excitatory amino acids such as glutamate and in the damaging effects produced by their
generation in excess (Dawson et al., 1991; Forstermann et al., 1991).Vascular NO is very
unstable in oxygenated media with a half-life of about 6 seconds.The short lifetime of
NO is generally attributed to the continuous presence of superoxide anions (Van Der
Vleit & Bast, 1992).
1.3.1.3 Peroxynitrate
The interaction of NO with superoxide radical leads to the formation of peroxynitrite
(ONOO
-
), a reaction that occurs at a threefold faster rate than that of the dismutation of
superoxide by SOD (Beckman et al., 1993).
O2- + NO . ONOO
- + H+  (1)
Therefore the formation of peroxynitrate depends on the concentrations of superoxide
and NO in the cell. Peroxynitrate is a highly reactive oxidising agent that can cause tissue
damage by an active intermediate that acts like an OH. radical. At physiological pH,
peroxynitrite may be able to diffuse over several cell diameters to produce cell damage
by oxidising lipids, proteins and DNA (Beal, 1997).
1.3.1.4 Hydroperoxyl Radical
Protonation of O2- yields the hydroperoxyl radical (HO2
.
). The pKa of HO2
.
 is 4.7 – 4.8
(Bielski & Allen, 1977)) so at physiological pH of around 7.4, not much HO2
. exists.
However, in close proximity to the membranes, the pH might be considerably lower than
this, and more superoxide will exist as HO2
.
. Although there is no clear evidence as to the
cytotoxic effects of HO2
. in any biological system, its potential importance arises from
two factors. Firstly, it is less polar than O2- and is thus capable of crossing biological
membranes as effectively as hydrogen peroxide (Halliwell & Gutteridge, 1986).
9Secondly, HO2
. is somewhat more reactive than O2-. It is capable of attacking fatty acids
directly and has been shown to convert linolenic, linoleic and arachidonic acids to
peroxides (Bielski et al., 1983). HO2
.
 has also been proven to initiate peroxidation of the
lipid component of low density lipoproteins (Bedwell et al., 1989).
1.3.1.5 Hydroxyl Radical
Apart from the damage it causes on its own, the superoxide anion secondarily forms
further reactive oxidants, by dismutation to hydrogen peroxide which can be converted to
the highly damaging hydroxyl radical or be catalysed and excreted harmlessly as water.
Hydroxyl radicals are short-lived and can be formed from O2- and H2O2 through the
Haber-Weiss reaction or through the interaction of metals such as iron or copper and
H2O2, through the Fenton reaction (Halliwell & Gutteridge, 1985) as shown in the
equations below.
O2
-
 + H2O2 H2O + OH 
-
 + OH
.     Haber-Weiss Reaction (2)
Fe3+ + O2- Fe2+ + O2
Fe2+ + H2O2 Fe3+ + OH
.
 + OH 
-  Fenton Reaction (3)
The OH. is capable of reacting with almost all molecules in living cells (Fridovich, 1986)
and no enzyme system involving it as a substrate exists (Bird & Iversen, 1974). The
hydroxyl radical has been implicated in damage to proteins, carbohydrates, DNA and
lipids (Reiter et al., 1995; Dawson & Dawson, 1996; Volterra et al., 1994).
1.3.1.6 Lipid Peroxidation
Although all of the major classes of biomolecules may be attacked by free radicals, lipids
are probably the most susceptible. Cell membranes are rich sources of polyunsaturated
fatty acids (PUFAs), which are readily attacked by oxidising radicals (Cheeseman &
Slater, 1993). Extensive lipid peroxidation in biological membranes results in alterations
in fluidity, fall in membrane potential, increased permeability to H+ and other ions, and
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eventual rupture leading to release of cell and organelle contents such as lysosomal
hydrolytic enzymes (Fong et al., 1973).
Although much attention is paid to malondialdehyde, various other toxic end products are
also formed as a consequence of lipid peroxidation, such as 4,5-dihydroxydecenal and 4-
hydroxynonenal (Benedetti et al., 1984; Esterbauer et al., 1988).
1.3.1.6.1 Mechanism of Lipid peroxidation
Fig.1.4 outlines the basic mechanism involved in lipid peroxidation. Any species which
has enough reactivity to abstract a hydrogen atom from a methylene group provides the
first step of a peroxidation sequence in a membrane. Abstraction of a hydrogen atom
from the methylene group leaves behind an unpaired electron on the carbon to which it
was originally attached. The presence of a double bond in the fatty acid weakens the C-H
bonds on the carbon adjacent to the double bond, facilitating the removal of H.
The carbon radical stabilises itself by a molecular rearrangement as depicted in Fig.1.4, to
form a conjugated diene, which, under aerobic conditions, can combine with oxygen to
form a peroxyl radical, ROO. or RO2.  The oxygen concentrations may alter the pathway
of peroxidation since at very low oxygen concentrations the carbon-centered radicals may
favour self-reaction or reactions with other membrane components such as proteins.
The peroxyl radicals formed can abstract H from another lipid molecule, possibly from an
adjacent fatty acid side chain. This stage of the reaction is called the propagation stage.
The carbon radical formed can react with oxygen to form another peroxyl radical and so
the chain reaction of lipid peroxidation continues. The length of the propagation chain
depends on factors such as the lipid/protein ratio in a membrane, the fatty acid
composition, oxygen concentration as well as the presence of chain-breaking
antioxidants, which are capable of interrupting the chain reaction by providing an easily
donatable hydrogen for abstraction by the peroxyl radicals (Halliwell & Gutteridge,
1990).
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FIG. 1.4 Mechanism of lipid peroxidation (Gutteridge &Halliwell; 1990).
1.3.2 EXCITOTOXICITY
Excitotoxicity is the paradoxical property exhibited by excitatory amino acids (EAA)
such as glutamate, of causing acute neuronal degeneration by excessive stimulation of
postsynaptic EAA ionotropic receptors, i.e. receptors through which glutamate functions
as a transmitter (Olney, 1995). Glutamate, the main excitatory neurotransmitter in the
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mammalian brain, has important roles in several physiological and pathological events.
Glutamatergic neurotransmission is achieved through ionotropic (ligand-gated ion
channels) and metabotropic (G protein-coupled) receptors (Ozawa et al., 1998).
Specifically, the NMDA ionotropic glutamate receptor subtype seems to be crucial in
plasticity processes associated with normal brain function. However, overstimulation of
the glutamatergic system, as observed when glutamate concentration in the synaptic cleft
increases, may be neurotoxic (Izquierdo & Medina, 1997; Ozawa et al., 1998).
There are two principle processes by which EAA causes neurotoxicity, based on the
differences in time course and ionic dependence. The first process is termed the acute
process and it is characterised by a rapid influx of sodium ions into the neuron, which
causes a passive entry of chloride ions and water into the cell through osmotic pressure.
This results in the rapid swelling of the neurons due to the excessive depolarisation, ion
influx and water entry (Tilson & Mundy, 1995).
The second process, delayed toxicity, is one that involves Ca2+ influx, which is mediated
by the NMDA receptor. The increased concentration of Ca2+ within the cells can trigger a
number of enzymatic and metabolic processes which are neurotoxic. Among these
processes is the activation of proteases such as calpain-1, which is capable of degrading
major neuronal structural proteins and inducing cytoskeletal breakdown (Seubert et al.,
1988). Ca2+ can also bind to calmodulin to form Ca2+-calmodulin complexes, which
modulate the activity of a large number of enzymes. This complex can also disrupt the
cytoskeleton, cause mitochondrial dysfunction and activate lipases (Scatton, 1994).
Ca2+ is also capable of activating the phospholipases, which can break down cell
membranes and liberate arachidonic acid. This can lead to the breakdown of Ca2+ stores
within the cells and thus further amplify the excitotoxic response. Moreover, arachidonic
acid liberation leads to synthesis of prostaglandins, the mechanism of the anti-
inflammatory response. Inflammatory cells have shown to produce ROS and reactive
nitrogen species (RNS) as a mechanism for attacking opsonised targets (Akiyama et al.,
2000).
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In 1989, Dawson and co-workers discovered a link between nitric oxide and excitatory
transmission in the nervous system. These authors also discovered that by increasing the
expression of neuronal nitric oxide synthase (NOS) in culture they could increase
glutamate neurotoxicity. Thus, neuronally originated nitric oxide was discovered to play
a critical role in behavioural function and can act as a trigger in the excitotoxic
mechanism (Dawson et al., 1993). As mentioned earlier, excess nitric oxide generation
within the neuron can, in the presence of superoxide, lead to the production of the
peroxynitrite radical (section 1.3.1.4).
The excitotoxic response is thus intimately related to the free radical generation in that
excitotoxins increase free radical production, and free radicals, in turn, increase glutamate
release extracellularly. Calcium entry into the neuron has been shown to be a trigger in
activating NOS, thus completing the cycle (Blaylock, 1999).
1.3.3 THE ROLE OF THE MITOCHONDRIA IN OXIDATIVE
STRESS AND EXCITOTOXICITY
Free radicals are sometimes formed as intermediates in mitochondrial and microsomal
electron transport systems (Fantone & Ward, 1985). A deleterious consequence of energy
production by the mitochondria is the production of free radicals such as the superoxide
anion and hydroperoxides. This is because oxygen acts as the terminal electron acceptor
within the electron transport chain (Fantone & Ward, 1985).
Impaired mitochondrial function leads to impaired cellular Ca2+ buffering and secondary
activation of voltage-dependent NMDA receptors. This can, in turn, lead to further
influxes of Ca2+, which are buffered in mitochondria, leading to increased production of
the superoxide anion. Moreover, the increase in Ca2+ results in an activation of neuronal
nitric oxide synthase (NOS). Nitric oxide reacts with O2- to generate ONOO- (as
discussed in section 1.3.1.3), which results in oxidative damage to DNA, proteins and
lipids (Beal, 1997). This is shown in Fig. 1.5 below.
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FIG. 1.5 The mitochondrion: a major source of cellular free radicals. (a) depicts
the effects of a severe excitotoxic insult that results in cell death by
necrosis, whereas (b) depicts the results of a mild excitotoxic insult that
results in apoptosis (Beal, 2000).
 As the diagram above depicts, the production of superoxide radicals can also lead to
increased H2O2 production, which can react with transition metals like iron (II). This
results in damage to cellular macromolecules like DNA, which leads to the activation of
poly-ADP ribose polymerase (PARS). Activation of PARS leads to ATP and NAD
depletion, which leads to death. Both mitochondrial accumulation of Ca2+ and oxidative
damage lead to activation of the permeability transition pore (PTP) that is linked to
excitotoxic cell death. The release of cytochrome c, caspase 9 and apoptosis inducing
factor (AIF) by the mitochondria is also linked to increased mitochondrial Ca2+ and free
radical production. These mediators lead to the activation of a caspase cascade, and
finally apoptotic death (Beal, 2000).
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1.3.4 NEUROTOXINS
Brain damage also results from chemical neurotoxicity, either from administered drugs or
environmental toxins. Many neurotoxic agents are available which mimic human
pathologies or are useful for the study of neurodegeneration because of their specificity in
effect. Kainate, an excitotoxic agent, is useful as a model of epileptogenesis and seizures
(Zaczek et al., 1980; Pennypacker et al., 1993). 1-Methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) administration, resulting in the selective death of
dopaminergic neurons in rodents, serves as a model for Parkinson's disease
(Freyaldenhoven et al., 1997).
1.3.4.1 Quinolinic Acid
Quinolinic acid (QA), an endogenous metabolite of tryptophan, is a potent endogenous
neurotoxin, first demonstrated by Lapin (1978). It is normally present in low nanomolar
concentrations in human brain and cerebrospinal fluid. However, substantial increase in
QA levels to micromolar concentrations are found in the brain and CSF of patients with
infectious and inflammatory neurological diseases (Heyes et al., 1996; Stone, 2000).
In spite of its involvement in many diseases, the exact molecular mechanism linking QA
and brain damage are far from being understood. However, some studies demonstrated
that QA exerts its toxicity in the central nervous system (CNS) via glutamatergic
receptors (Stone, 2001). Glutamate neurotoxicity is implicated in acute neurological
disorders as well as in neurodegenerative diseases (Lipton & Rosenberg, 1994).
Evidence suggests that QA is associated with neuronal damage through the
overactivation of the postsynaptic NMDA subtype of glutamate receptors (Stone, 2001).
Striatal administration of QA is associated with neurotoxicity and development of
neurological damage, which resembles that observed in Huntington’s disease, and
probably results from excessive NMDA receptor activation (Beal et al., 1991; Malcon et
al., 1997). Moreover, intracerebroventricular injection of QA has been shown to induce
seizures (Lapin, 1978; Schmidt et al., 2000; Lara et al., 2001).
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The neurotoxicity produced by QA may also depend at least partly on the formation of
ROS, since its neurotoxic activity can be prevented by spin-trap reagents such as a-
phenyl- t-butylnitrone (Nakao & Brundin, 1997) and free radical scavengers (Nakai et al.,
1999). QA has also been shown to induce lipid peroxidation (Rios & Santamaria, 1991)
which can be prevented by nitroarginine and potentiated by L-arginine, suggesting that
NO, a free radical itself and a precursor of potent toxic radicals such as peroxynitrite,
may contribute to the activity of QA (Santamaria et al., 1997).
1.3.4.2 Cyanide
Numerous biochemical, morphological and physiological studies have shown that
cyanide is a potent and selective neurotoxin whose toxicity is mediated through histotoxic
hypoxia, consequent to mitochondrial dysfunction (Bhattacharya & Lakshmana Rao,
2001). The cascading effects of cyanide-induced impairment of mitochondrial energy
production include failure of ionic homeostasis, acidosis, elevated Ca2+ levels and lipid
peroxidation, leading to activation of proteases, lipases, xanthine oxidases, etc. (Maduh,
1989). The elevation in brain calcium (Johnson et al., 1986) and increase in free cytosolic
calcium leads to increased oxidative stress and excitotoxcity.
The implication of oxidative stress and activation of endonucleases in oligonucleosomal
cleavage of DNA following cyanide exposure is well documented (Trump & Berezesky,
1995). Subsequent to oxidative stress, widespread DNA fragmentation leading to an
apoptotic type of cell death has been documented in cyanide poisoning (Mills et al.,
1996; Mills et al., 1999), with Mills et al. (1996) reporting an apoptotic effect of cyanide
in terminally differentiated PC12 cells. Cyanide also causes surface blebbing and
cytoarchitectural defects of neuronal cells as a consequence of Ca2+-activated
phospholipases and proteases (Nicotera et al., 1989).
1.3.4.3 Metals
Multivalent transition metals such as iron, copper, and manganese are essential in most
biological reactions such as the synthesis of DNA, RNA, and proteins. These are also
cofactors of numerous enzymes, particularly those involved in respiration. However,
abnormal tissue accumulation of redox-active transition metals can be cytotoxic because
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perturbations in metal homeostasis results in an array of cellular disturbances
characterised by increased free radical production (Campbell, 2001).
The levels of copper and iron are increased in the rims of senile plaques (SP) (Lovell et
al., 1998) and the presence of these redox reactive metals in both SP and neurofibrillary
tangles, has been shown to induce hydrogen peroxide dependent oxidation (Sayre et al.,
2001). This indicates that the metals may play a role in modulating oxidative events,
which may eventually result in neurodegeneration.
Transition metal ions are effective catalysts in unsaturated lipid peroxidation and are
therefore involved in membrane lipid peroxidation through free radical production.
Hydrogen peroxide, a by-product of oxidases, has been considered a messenger for
intracellular redox signaling pathways. In the presence of redox-active transition metal
ions such as iron and copper, H2O2 is converted to reactive hydroxyl radicals via the
Fenton reaction as shown below.
Mn+ + H2O2 M(n+1) + OH+ + OH- (5)
Recently it has been discovered that transition metals bind to proteins involved in
neurodegeneration and this association appears to preserve metal redox activity in a
manner that is consistent with a pro-oxidant, free radical generating action (Campbell et
al., 2001). Whereas transition metal ions can initiate the formation of ROS in vivo, main
group essential metal ions may limit oxidative damage through direct or indirect
competition with these. This is especially the case with zinc (Favier, 1995) and
magnesium (Rayssiguier & Mazur, 1995).
1.3.4.3.1 Iron
Free iron, more than any other transition metal, has been implicated in redox transitions
and consequent generation of oxygen free radicals. The potential of iron to cause an
increase in oxidative events leading to cellular damage is controlled by a series of iron-
binding proteins (Campbell, 2001).  Lactoferrin, which has been shown to protect against
severe inflammation, is increased in the brain of patients with neurodegenerative diseases
(Fillebeen et al., 1999). The large amounts of polyunsaturated fatty acids present in the
18
brain are extremely sensitive to iron-induced oxidative stress and readily undergo lipid
peroxidation in the presence of iron (Chiueh, 2001).
Haemoglobin has been postulated to be the major source for iron overload in the brain
during the breakdown of the blood brain barrier (BBB) by promoting the generation of
ROS, lipid peroxidation, axonal dystrophy and neurodegeneration. These deleterious
effects of haemoglobin are blocked by desferrioxamine in vitro and in vivo, suggesting
the involvement of free iron released from haemoglobin (Bergen et al., 1999).
Microglia are the major sites of ferritin bound iron and are thought to be partly
responsible for oxidative damage in Parkinson’s disease and other neurodegenerative
disorders. Abnormally high levels of iron as well as oxidative stress have been
demonstrated in a number of neurodegenerative disorders including Alzheimer’s disease
and those characterised by nigral degeneration such as Parkinson’s disease, multiple
system atrophy, and progressive supranuclear palsy (Campbell, 2001).
Moreover, the interplay between oxidative stress and control of iron metabolism in the
brain is exemplified by the finding of abnormal iron deposition associated with lipid
peroxidation in a transgenic mouse model of a BBB defect linked to progressive
neurodegeneration (Castelnau et al., 1998).
1.3.4.3.2 Lead
Lead is one of the most widely used nonferrous metals that is present in the environment.
Lead toxicity results from exposure to contaminated air, water, food, soil and other lead-
contaminated non-food ingestants (Keogh, 1992). It interferes with haem metabolism,
causes widespread tissue damage and antagonises many biological actions of Ca2+ ions
(Dulka & Risby, 1976; Simons, 1986).
Several lines of evidence suggest that cellular damage mediated by oxidants is involved
in some of the pathologies associated with lead intoxication. Lead is known to potentiate
O2 toxicity in rats (Kiesow, 1977), stimulate oxidative haemolysis of erythrocytes
(Gelman et al., 1978), decrease erythrocyte superoxide dismutase activity (Gelman et al.,
1978; Ito et al., 1985) and accelerate the conversion of oxyhaemoglobin to
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methaemoglobin, with the accompanying production of superoxide radicals and hydrogen
peroxide (Ribarov & Bochev, 1982).
Lead has also been suggested to accelerate lipid peroxidation in vivo (Ribarov & Bochev,
1982) and it was observed to increase the rate of peroxidation of liposomes in the
presence of haemoglobin (Ribarov et al., 1981). Quinlan et al. (1988) reported an
enhancement of Fe2+ initiated lipid oxidation in liposomes, erythrocytes, microsomal
fractions and rat brain homogenates in the presence of lead.
A hypothesis that has been studied for many years is that lead is toxic by disrupting
calcium-dependent mechanisms. Lead and calcium compete for the same binding sites on
proteins that belong to a large family of ion binding proteins and lead often substitutes for
calcium in such proteins (Habermann et al., 1983). Members of this family include
calmodulin, calretinin, calbindin and parvalbumin.
Furthermore, the dendritic branching observed in hippocampal neurons that were exposed
to KN-62, an inhibitor of calmodulin – dependent protein kinase II, was blocked by lead
(Kern & Audesirk, 1995). Dendritic branching is a mechanism essential in developing the
learning process. Hence the effects of lead on calmodulin-dependent proteins may
explain deficits observed in learning caused by lead exposure.
1.3.4.3.3 Cadmium
Cadmium is an abundant element of worldwide concern because it accumulates in the
environment as a result of its manifold industrial uses. Discharges mainly from industries
such as electroplating, plastic production, pigment and battery manufacturing, coal
burning power plants, sludge from sewage treatment plants used as fertilizer, gas from
the municipal incinerators, pesticides and cigarette smoking (Friberg, 1986) are the main
sources of cadmium. Once absorbed, the extremely long biological half-life of cadmium
(16 to 32 years) allows cadmium to slowly accumulate in the body (Nath et al., 1984).
The picture of cadmium neurotoxicity is comprised of behavioural, neurochemical and
histopathological effects (Murphy, 1996). Motor abnormalities, physiological
dysfunctions in the nervous system and decreased intelligence are the main symptoms
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observed in both children and adults exposed to cadmium (Taylor & Ennever, 1993;
Thatcher & Lester, 1989).
 Entry of cadmium into the brain is prevented by the BBB and the cerebrospinal fluid
(CSF) barriers (Takeda et al., 1999). However, Shukla et al. reported that BBB
permeability is enhanced by chronic exposure to cadmium (Shukla et al., 1996). In
animal studies, chronic exposure to cadmium causes significant increases in cadmium
concentration in the brain, especially in the olfactory bulb (Clark et. al, 1985; Evans &
Hastings, 1992).
Cadmium accumulation in the brain causes behavioural alteration, which is exacerbated
in rats fed with low protein diet (Ali et al., 1991). Chronic exposure of rats to cadmium
resulted in significant changes in the regional concentration of brain biogenic amines,
namely a suppression of cortical acetylcholine and brain stem 5-hydroxytryptamine and
an accumulation of striatal dopamine. Consequent to cadmium exposure, concentrations
of lipid peroxidase are significantly elevated in the cerebellum, cerebral cortex, corpus
striatum and midbrain (Shukla et al., 1987). Based on the formation of thiobarbituric acid
reactive substances (TBARS), cadmium has been shown to increase lipid peroxidation in
various organs of adult rats, with the lungs and brain being the main targets (Manca et al.,
1991).
Cadmium (II) is also known to decrease SOD activity as well as reduce the concentration
of antioxidants such as vitamin E and C, in the liver and brain of treated rats (Sugiyama,
1994). It is suggested that cadmium (II) directly or indirectly through inhibition of
superoxide dismutase, increases the lipid peroxidase levels of cell membranes and thus
inhibits the associated physiological functions, leading to CNS dysfunction.
1.4 NEURODEGENERATIVE DISORDERS
In a structure as complex as the human brain, a multitude of things can go wrong.
Disorders of the brain may occur in its structural architecture or in its electrical and
chemical processes and the evidence for a role of oxidative damage in neurodegenerative
diseases is becoming increasingly compelling. Pathological processes in the brain can be
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brought about as a result of proximate and remote factors that may be classified as either
genetic or environmental (Kety, 1979).
1.4.1 AGEING
The rate of ageing of an animal appears to be determined primarily by genetic factors.
Thus the maximum lifespan of an animal is genetically determined, and hence it does not
appear that significant manipulation of this maximum lifespan is possible utilising the
techniques of free radical biology (Pryor, 1982; 1984). However, the lifespan of
individuals in a population varies with stress, and free radicals play an important role in
stress (Pryor, 1986). Free radicals increase ageing both by influencing the rate of
development of specific chronic diseases and by causing general “wear and tear” on
biopolymer molecules. The argument that free radicals cause general, non-specific
damage to biopolymer molecules is called the “free radical theory of ageing” (Harman,
1982).
This theory is a popular hypothesis that has been used to explain the ageing process
(Fantone & Ward, 1985). The intracellular generation of free radicals results in a
progressive accumulation of defective molecules in the cells. This causes an alteration in
the physiological function including the accumulation of the lipofuscins (“age-
pigments”). Biochemical characterisation of these pigments indicates that they consist
largely of oxidised lipids (Taubald et al., 1975). Several other studies support a
relationship between that of free-radical production within tissues and life span (Fantone
& Ward, 1985).
It has been postulated that a reduced caloric intake could result in the decreased
production of free radicals as by-products of normal biochemical reactions in cells,
especially oxygen metabolic products of mitochondrial respiration (Harman, 1982). The
correlation that exists between age and the onset of specific diseases in which free radical
reactions are important, further supports the hypothesis that free radicals are intimately
involved in the ageing process (Fantone & Ward; 1985).
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Moreover, the aged brain has been shown to be more susceptible to ROS damage since
many of the neuroprotective pathways are no longer as effective as they are in younger
animals. The production of the neurohormone, melatonin, is also affected with age
(Ludolph, 1995). This is probably because of the reduction in the number of b-adrenergic
receptors (responsible for mediation of night time increase in melatonin production) with
age (Saarela & Reiter, 1993). Another reason may be that the neuronal message to the
pineal gland in older animals may be weakened by the gradual deterioration in the cells
of the hypothalamic suprachiasmatic nuclei due to the action of EAA on the neurons at
this level (Reiter et al., 1996).
1.4.2 ALZHEIMER’S DISEASE
A case report was published by Alois Alzheimer in 1907, describing the cerebral cortex
of a 55-year old woman with progressive dementia (Alzheimer, 1977). The famous
“note” pointed out the presence of abnormal nerve cells that contained tangles of fibres
(neurofibrillary tangles) and clusters of degenerative nerve endings (neuritic plaques).
This presenile dementia later became known as Alzheimer’s disease (AD).
AD involves the selective and progressive degeneration of the lower motor neurons in the
spinal cord and the upper motor neurons in the cerebral cortex and is characterised by a
progressive amnesic syndrome and loss of parietal and frontally based skills (Coyle &
Puttfarcken, 1993). The characteristic pathology includes cerebral atrophy,
neurofibrillary tangles, b-amyloid-containing plaques and gliosis. The cortex,
hippocampus and amygdala are most affected (Barrett, 1993).
There is a marked dimunition of acetylcholine transferase, the biosynthetic enzyme for
acetylcholine and this decrease is selective for the regions in which senile plaques and
neurofibrillary tangles are found. Degeneration of cholinergic neurons is pronounced in
these areas. Reports of loss of serotonin in the hippocampal region have also been
reported (Bannister, 1992).
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Substantial evidence for increased oxidative damage in AD exists from studies of
postmortem brain tissue. There are consistent increases in lipid peroxidation as assessed
by increases in malondialdehyde concentrations (Beal, 1997). Studies using novel spin-
trapping techniques showed oxidative damage to both lipids and proteins (Hensley et al.,
1995). Amyloid b-protein which is derived from the amyloid precursor protein (APP)
accumulates in plaques and has been implicated in neurotoxicity, where it is thought to
induce the production of free radicals (Behl et al., 1994, Goodman & Mattson, 1996) and
disrupt calcium homeostasis (Mattson et al., 1992).
It has been shown that patients with AD appear to suffer from diminished amplitude in
the melatonin acrophase (Bevier et al., 1992). This finding, in conjunction with other
factors, has led to the conclusion that melatonin may be able to protect against AD.
Rodent experimentation has demonstrated that pharmacological treatment with melatonin
prevents premature ageing and delays the onset of various neurodegenerative diseases
(Poeggeler et al., 1993).
1.4.3 PARKINSON’S DISEASE
The possibility that oxidative damage may play a role in the pathogenesis of Parkinson’s
disease (PD) has aroused much interest. Mitochondrial complex I defects have been
found in the substantia nigra, muscle and platelets of Parkinson’s diseased patients (Beal,
1997). Direct evidence for oxidative damage comes from two studies, which show
increased malondialdehyde and increased cholesterol hydroperoxides in the substantia
nigra of Parkinson’s diseased patients (Sanchez-Ramos et al., 1994).
An indirect measure of oxidative stress is reduced glutathione concentration. Decreased
glutathione concentrations in PD substantia nigra have been found in four separate
studies (Perry et al., 1982; Riederer et al., 1989; Sofic et al., 1992; Sian et al., 1994).
Furthermore, reduced glutathione concentrations are found in patients with incidental
Lewy bodies in the substantia nigra, which may be a presymptomatic phase of PD
(Dexter et al., 1994).
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Further evidence implicating oxidative damage in the pathogenesis of PD comes from
studies of MPTP neurotoxicity. MPTP produces a Parkinsonian syndrome that closely
mimics findings that occur in idiopathic PD. The pathogenesis of the lesions involves
inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium (MPP+), the
active metabolite of MPTP. MPP+ results in increased free radical generation in vivo, and
the toxicity of MPTP is attenuated in mice overexpressing SOD (Przedborski et al.,
1992). Schulz et al. (1995) showed that 7-nitroindazole, a relatively selective inhibitor of
the neuronal isoenzyme of NOS, produces dose-dependent inhibition of MPTP
neurotoxicity accompanied by reduced striatal concentrations of 3-nitrotyrosine. 7-
nitroindazole produced complete protection against MPTP neurotoxicity in baboons
(Hantraye et al., 1996). These findings suggest that peroxynitrite plays a role in MPTP
neurotoxicity and, by implication, in PD.
1.5 MECHANISMS OF NEUROPROTECTION
1.5.1 DEFENCES AGAINST FREE RADICALS
Due to the inevitable damages caused by free radical production in animal cells, defences
within the body have evolved. These are known as antioxidant defences and may be
categorised into those whose role is to prevent the generation of free radicals, and those
that intercept any that are generated. These are present in both the aqueous and the
membrane compartment of the cell and can be enzymes or non-enzymes (Cheeseman &
Slater, 1993).
The principal defence systems against oxygen free radicals are SOD, GSH (reduced form
of glutathione), GSH peroxidases, glutathione reductase, catalase (a haem enzyme), and
antioxidant nutrients (Fig. 1.6).
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FIG. 1.6 Removal of oxygen and nitrogen free radicals and other reactive species
in mammalian cells (Fang et al., 2002).
Vitamin E can transfer its phenolic hydrogen to a peroxyl free radical (LOO
.
) of a
peroxidised PUFA, thereby breaking the radical chain reaction and preventing the
peroxidation of PUFA in cellular and subcellular membrane phospholipids. As a reducing
agent, vitamin C reacts with a vitamin E radical to yield a vitamin C radical while
regenerating vitamin E. Like a vitamin E radical, a vitamin C radical is not a reactive
species because its unpaired electron is energetically stable. A vitamin C radical is
converted back to vitamin C by GSH (Fang et al., 2002).
Cytochrome C and SOD catalyse the formation of O2 from O2- as shown in Fig. 1.6. A
co-product of SOD is H2O2, which is converted to H2O by catalase (CAT) and the
selenium-dependent GSH peroxidase. Lipid hydroperoxides (LOOH) are detoxified to
alcohols by GSH peroxidase. Other ROS as well as RNS scavengers include uric acid (a
metabolite of purines), salicylate, mannitol, carotenoid, ubiquinone, bilirubin (a product
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of haemoglobin catabolism), a-lipoate, arginine, citrulline, glycine, taurine, histidine,
creatine (a metabolite of arginine, glycine and methionine), carnosine (b-alanyl-L-
histidine, which is abundant in skeletal muscle), tetrahydrobiopterin (a metabolite of
guanosine triphosphate and thus glutamine), phytate, and tea polyphenols (Fridovich,
1999; Lawler, 2002; Machilin & Bandito, 1987;Wu & Meininger, 2000; Lass et al., 2002;
Akashi et al., 2001; Redmond et al., 1996).
Due to the continuous generation of superoxide anions in the mitochondria, the
mitochondria possess an efficient antioxidant system composed of superoxide dismutase,
glutathione peroxidase, glutathione reductase, glutatione, NAD(P) transhydrogenase,
NADPH, vitamins E and C (Sutton & Winterbourn, 1989; Halliwell & Gutteridge, 1989),
thiol peroxidases such as SSP-22 (Watabe et al., 1997) and mitochondrial respiration
itself (Guidot et al., 1995).
Steroid hormones have been reported to have antioxidant neuroprotective properties,
oestrogen being particularly important (Goodman et al., 1996; Behl et al., 1997). They
have previously been reported to be a more potent inhibitor of iron-catalysed lipid
peroxidation in brain tissue than vitamin E (Behl et al., 1992; Hall et al., 1991). With
regard to AD, it has been demonstrated in vitro that 17-b-estradiol protects neurons from
Ab-mediated cytotoxicity (Behl et al., 1995) and from oxidative insults attenuating
membrane lipid peroxidation and stabilising neuronal calcium homeostasis (Goodman et
al., 1996; Keller et al., 1997).
1.5.2 MELATONIN
Melatonin (5-methoxy-N-acetyl-tryptamine) is an indoleamine synthesised from
tryptophan predominantly in the pineal gland and other organs in vertebrates (Reiter et
al., 2000). The synthesis of the hormone is under rhythmic control (Reiter, 1987) with
peak levels produced at night in darkness. Melatonin has been demonstrated to be a
powerful antioxidant and free radical scavenger (Tan et al., 1993) and thus prevents
oxidative damage to the cell membrane, cytosol organelles and nuclear and mitochondrial
DNA .
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Melatonin has been shown to scavenge reactants including the hydroxyl radical and
hydrogen peroxide as shown in Fig. 1.7, as well as, nitric acid, peroxynitrite and
peroxynitrous acid.
FIG. 1.7 Melatonin: a scavenger of both OH. and H2O2 as shown above, with the
resulting products being cyclic 3-hydroxymelatonin and N1-acetyl-N2-
formyl-5-methoxy-kynuramine, respectively (Reiter et al., 2002).
One of the products of melatonin’s interaction with hydrogen peroxide, N1-acetyl-N2-
formyl-5-methoxykynuramine (AFMK), is also a highly efficient radical scavenger
(shown in Fig. 1.7). The cascade of reactions where the secondary metabolites are also
effective scavengers is believed to contribute to the high efficacy of melatonin in
reducing oxidative damage (Reiter et al., 2002).
In addition, melatonin stimulates the synthesis of antioxidant enzymes including
superoxide dismutase, glutathione peroxidase and glutathione reductase (Pablos et al.,
1998; Albarran et al., 2001) suggesting that melatonin may act not only directly against
free radicals, but also indirectly as an enzyme stimulator, although the specific induction
mechanism is unknown (Albarran et al., 2001). Moreover, patients with AD have
decreased levels of melatonin in the periphery and the administration of this indole
induces improvement in circadian rhythms and insomnia in these patients (Monti &
Cardinali, 2000).
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1.6  PHYTOCHEMICALS
Animal studies have shown that dietary phytochemical antioxidants are capable of
removing free radicals. Among them, phenolic and polyphenolic compounds, such as
flavonoids and catechin in edible plants, exhibit potent antioxidant activities (Fang,
2002). A broad definition of the term, phytochemical, would be any compound found in
plants. However phytochemical is more commonly used to define the biologically active
molecules in plants that are not classified as vitamins or nutrients by more traditional
definitions.
The number of phytochemicals in plants is staggering, and though research into their
biological significance in humans is in its infancy, it has thus far yielded important
observations.  While phytochemicals have key functions in plants, they may also play a
significant role in human health (Technical Bullein, 1998). As animal species evolved,
many were able to "borrow" some of the protective phytochemicals from the plants
composing their diets, saving these species the trouble of having to manufacture all their
own chemical defence mechanisms.
Plants have developed extensive systems for managing reproduction, response to injury,
protection from ultraviolet light, and resistance to disease. Attending to these important
functions requires communication between plant cells and between the plant and its
environment.  Plants use phytochemicals, both as a means of communication and as a
response to environmental stress. “Communication” also occurs between phytochemicals
and the human organism when we eat plant-based foods.  This communication involves a
number of complex biological activities that influence health.  While it is hard to quantify
the exact amount of phytochemicals consumed by individuals, dietary consumption of
flavonoids, one class of phytochemicals, is estimated to be between 23mg and 1 g/day
(Hertog et al., 1993; Kuhnau, 1976).
The process by which the plant produces the chemicals needed for communication, i.e.,
signalling molecules, is referred to as secondary metabolism (Technical bulletin, 1998).
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The secondary metabolites produced from this process influence diverse communication
activities. For example, carotenoids provide colour to signal pollinators such as birds, and
polyphenols such as those present in grape skins, protect DNA from damage in dry
and/or light intensive environments (Das et al., 1994).
1.6.1 BIOLOGICAL ACTIVITIES INFLUENCED BY
PHYTOCHEMICALS
The diversity of the phytochemical family is reflected in the number of biological
activities which these molecules exhibit.  Phytochemicals can act as potent antioxidants,
can specifically inhibit or activate different enzyme systems in the body, and can effect
gene expression and influence the types of molecules our cells synthesise.  Different
phytochemicals have been shown to possess anticarcinogenic, anti-inflammatory, and
antiallergic properties (Caragay, 1992).
1.6.1.1 Phytochemicals as Antioxidants
The ability to act as antioxidants in some capacity is a common pathway shared by many
phytochemicals. Interest in the antioxidative abilities of phytochemicals was generated in
the mid 1930’s when Szent-Gyorgi discovered a class of polyphenolic compounds that
were more potent than vitamin C in treating scorbutic guinea pigs. This researcher termed
this class of molecules “vitamin P” to reflect their ability to reduce capillary permeability
(Liebovitz and Mueller, 1993). Since then it has been discovered that many
phytochemicals have the ability to act as antioxidants, some even more potent than
vitamins E or C due to their ability to donate single electrons (Technical Bulletin, 1998).
1.6.1.2 Phytochemicals as Modulators of Key Enzymes in
Biological Pathways
Recent studies show that certain phytochemicals may have specific effects on enzyme
pathways in the body. Much focus has been placed on one of the main pathways that
contribute to chronic conditions such as inflammation: the arachidonic acid cascade.
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Several enzymes in the arachidonic acid cascade have been shown to be modulated by
different phytochemicals (Fig. 1.8.).
FIG. 1.8 Modulation of key enzymes in the arachidonic acid cascade by
phytochemicals (Technical Bulletin, 1998). 
1.6.1.3 Phytochemicals as Anti-inflammatory agents
The inflammatory process is a complex cascade, which involves the activation of the
arachidonic acid cascade and release of oxidants as well as other chemical mediators that
include eicosanoids (prostaglandins, prostacyclins, leukotrienes and thromboxanes),
cytokines (e.g. tumour necrosis factor) and ROS. The controlled production and
subsequent down-regulation of these inflammatory mediators produces acute
inflammation, which is a process essential for maintaining health. When these
inflammatory mediators are not down-regulated and continue to be produced, chronic
inflammation results, and this leads to an excessive production of cytokines, eicosanoids
and ROS.
Various phytochemicals have been shown to play important roles in combating chronic
inflammation. Quercetin, found in onions and apples, has been shown to inhibit several
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enzymes with pro-inflammatory activity in the arachidonic acid cascade, such as 5-
lipoxygenase and cyclooxgenase (Carmen et al., 1995). Hesperidin is a flavonoid found
in citrus foods and is capable of inhibiting arachidonic acid and histamine release, actions
that are thought to support its anti-inflammatory and analgesic properties (Emim et al.,
1994).
Phytochemicals are subdivided into different classes of compounds based on chemical
structure and synthesis pathways, and are grouped into at least 14 general classes:
carotenoids, coumarins, flavonoids, glucurates, indoles, isothiocyanates, lignans, mono-
terpenes, di- and tri- terpenes, phenolic acids, phthalides, phytates, polyacetylenes, and
sulfides. Of these, the flavonoids are the largest class, with over 4000 representatives
(Hollman and Katan, 1998).
1.6.2 FLAVONOIDS
Flavonoids are brightly coloured chemical constituents found in most fresh fruit,
vegetables and herbs.  These are a ubiquitous group of polyphenolic substances occuring
in high concentrations in the juice and peel of citrus fruits, and are also present in onions,
grapes, wine and greens. Flavonoids have been shown in a number of studies to be potent
antioxidants, capable of scavenging hydroxyl radicals, superoxide anions, peroxynitrite
and lipid peroxyl radicals (Reuben, 1994). Several flavonoids are also known to be very
effective metal chelators (Duthie et al., 1997).
These phytochemicals can also inhibit free radical injury to neurons by inhibiting
glutamate toxicity in a dose-dependent manner (Schubert et al., 1992). These are also
known to spare ascorbic acid and may spare the tocopherols as well, both of which
significantly reduce excitoxicity (Hertog & Katan, 1998). Most flavonoids are present in
plants as glycosides. In the intestines, this moiety is cleaved off leaving the aglycone
form of the flavonoid (Griffiths, 1982). It is the aglycone form that is thought to have the
highest antioxidant activity in biological systems.
1.6.3 TURMERIC
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Turmeric is a member of the Curcuma species of the family Zingiberaceae (Fig. 1.9). The
root and rhizome is crushed and powdered into ground turmeric. Turmeric is an ancient
spice and a traditional remedy that has been used as a medicine, condiment and
flavouring agent within both Chinese and Indian systems of medicine (Thaloor et al.,
1998).
FIG. 1.9 Fresh rhizomes of turmeric (www-ang.kfunigraz.ac.at/~katzer/
engl/Curc_dom.html)
Turmeric has been used in Ayurvedic medicine for several thousand years in India for a
number of medical conditions including treatment of common colds, coughs, jaundice,
and upper respiratory disorders.  In old Hindu texts it is ascribed for its aromatic,
stimulant, and carminative properties. Turmeric mixed with slaked lime is known as a
household remedy for the treatment of sprains and swellings cased by injury.  For this
purpose it is applied locally over the affected area. East Indian healers have also been
reported to use turmeric as an antiviral agent and a stomach aid.
Besides its well-known medicinal history, turmeric is what gives curry dishes their
distinctive colour and flavour. Ethnologically, Curcuma longa still occupies an important
position, as every food should contain it in India. Religious ceremonies also, always
make use of turmeric in any form.  Raw turmeric contains 0.3 – 5.4% curcumin, 4 – 14%
volatile oils including tumerone, atlantone, and zingiberone. Turmeric also contains
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sugars (28% glucose, 12% arabinose), proteins and resins (Leung, 1980; Ammon &
Wahl, 1991).
1.6.4 CURCUMIN
Turmeric is a rich source of a group of phenolic compounds called curcuminoids. Three
main curcuminoids namely curcumin, demethoxycurcumin and bisdemethoxycurcumin
occur naturally in these Curcuma species. Curcumin is the major yellow colouring
pigment found in the Curcuma species, Zingiberaceae.
1.6.4.1 Chemistry
Although the chemical structure (Fig. 1.10) of curcumin was determined by Lampe in
1910 (Ammon & Wahl) it was only in the seventies and eighties that the potential uses of
curcumin in medicine has been extensively studied.
FIG. 1.10 Structural representation of the three curcuminoids.
Curcumin: R1= R2 = OH R3 = R4 = OCH3
Demethoxycurcumin: R1 = R2 = OH R3 = H; R4 = OCH3
Bisdemethoxycurcumin: R1 = R2 = OH R3 = R4 = H
As shown above, the primary structure of curcumin is a conjugated diene with an
adjacent phenolic group that has general antioxidant property. It has been reported that in
addition to the phenolic group, the methoxy group on the phenyl ring and the 1,3-
diketone system are also important structural features that contribute to its antioxidant
properties (Sreejayan et al., 1996). It is insoluble in water but soluble in ethanol, alkalis,
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ketone, acetic acid and chloroform. The main chain of curcumin is aliphatic and
unsaturated and the aryl group can be substituted or not.
1.6.4.2 Biological Activities
Curcumin (1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) has been
shown to have a dual effect in oxygen radical reactions, it can act as a scavenger of
hydroxyl radicals or catalyse the formation of hydroxyl radicals, depending on the
experimental conditions (Tønnesen, 1989; Kunchandy & Rao, 1990).
Curcumin inhibits lipid peroxidation in rat liver microsomes, erythrocyte membranes and
brain homogenates (Reddy & Lokesh, 1992; Salimath et al., 1986; Sharma, 1976) and
this has led to the postulation that curcumin could be useful as an anti-atherogenic agent
in those processes which occur as a consequence of a marked increase in blood lipid
peroxidation, such as myocardial infarction (Santos et al., 1989) and diabetes (Yagi,
1989). Curcumin also inhibits the induction of NOS in activated macrophages and has
been shown to be a potent scavenger of free radicals as well as nitric oxide (Sreejayan &
Rao, 1997).
Pharmacological actions of curcumin as an anti-inflammatory agent have been examined
by Srimal & Dhawan (1973) who showed that this compound was effective in acute as
well as chronic models of inflammation. The same authors report curcumin to be less
effective in adrenalectomized rats suggesting a participation of corticoidal steroids in the
anti-inflammatory action of curcumin (Srimal & Dhawan, 1985).
Huang et al. (1991) reported an inhibitory effect of curcumin on arachidonic acid-
induced inflammation and on arachidonic acid metabolism through the inhibition of
cyclooxygenase (COX) and lipooxygenase (LOX) enzymes in mouse epidermis. COX is
a bifunctional enzyme with cyclooxygenase and peroxidase activities (Zhang et al., 1999;
Campbell & Halushka, 1996). The cyclooxygenase activity of COX is important for the
initial conversion of arachidonic acid to prostaglandin G2, and the peroxidase activity of
COX then converts it to prostaglandin H2. Finally, prostaglandin H2 is converted to other
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prostaglandins by a variety of tissue specific enzymes. These prostaglandins then exert
their biological actions on these tissues (Campbell & Halushka, 1996).
Conventional non-steroidal anti-inflammatory drugs (NSAIDS) do not inhibit the
peroxidase function of the COX enzyme, which potentially limits their efficacy as
anticancer agents whereas curcumin inhibits both the cyclooxygenase and peroxidase
activities of this enzyme (Zhang et al., 1999). The anti-cancer action of curcumin has
been studied in a standard model of radiation-induced tumour in rat mammary gland and
was reported to have decreased the incidence and proportion of tumours by 50% (Inano et
al., 2000). Likewise, Limtrakul et al. (1997) showed an inhibitory effect of curcumin on
mouse skin carcinogenesis initiated by 7,12-dimethylbenz(a)anthracene (DMBA) and
promoted by tetradecanoylphorbol-13-acetate (TPA).
As a result of its immune-modulating, anti-inflammatory and cycloxygenase inhibitory
action curcumin shows a favourable effect on a mouse model of psoriasis (Miquel et al.,
2002). A study by Heng et al. (2000) on patients with active psoriasis showed that topical
treatment with curcumin results in resolution of psoriatic activity as assessed by clinical,
histological and immunological criteria and the authors postulate this anti-psoriatic
activity of curcumin to be due to the modulation of phosphorylase-kinase (PhK) activity
that integrates multiple calcium/calmodulin-dependent signaling pathways. The PhK
activity is found to be high in untreated psoriasis and was decreased to near normal
values by curcumin treatment. An overall view of the biochemical actions of curcumin is
listed below:
Biochemical Action of curcumin Reference
Scavenges superoxide anion and hydroxyl                Kunchandy & Rao (1990).
radical.
Scavenges singlet oxygen. Subramanian et al. (1994).
Inhibits lipid peroxidation. Sreejayan (1994).
Inhibits TPA-induced ornithine decarboxy- Huang et al. (1988).
lase mRNA and activity.
Inhibits TPA-induced cellular Shih & Linn (1993).
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8-hydroxydeoxyguanosine.
Inhibits TPA-induced skin inflammation. Huang et al. (1997).
Inhibits lipoxygenase and cycloxygenase Huang et al. (1991).
activities.
Inhibits arachidonic acid metabolism. Conney et al. (1991).
Inhibits the formation of carcinogen-DNA Conney et al. (1991).
adducts.
Inhibits skin tumor initiation and promotion Huang et al. (1992).
Inhibits azoxymethane-induced colon tumo-
rigenesis in mice and rats. Rao et al. (1995). 
1.6.4.3 Biotransformations of Curcumin
1.6.4.3.1 Chemical Degradation
Curcumin is affected by UV under solar light exposure and the degradation kinetics of
curcumin under various pH conditions were investigated by Wang et al. (1997). The
results of the study showed that decomposition of curcumin is pH-dependent and occurs
faster under neutral-basic conditions. Based on mass and spectrophotometrical analysis,
trans-6-(4’-hydroxy-3’-methoxyphenyl)-2,4-dioxo-5-hexenal was identified as the major
degradation product, while vanillin, ferulic acid and feruloylmethane were identified as
minor degradation products as depicted in Fig. 1.11 (Wang et al., 1997).
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FIG. 1.11 Chemical degradation of curcumin in aqueous solution (Wang et al.,
1997).
1.6.4.3.2 Biotransformations of Curcumin in Mice
Pan et al. (1999) investigated the nature of the metabolites of curcumin in vivo and
showed that curcumin is first biotransformed into dihydrocurcumin and
tetrahydrocurcumin. These compounds are then converted to monoglucuronide
conjugates. The results of their experiments pointed at curcumin-glucuronide,
dihydrocurcumin-glucuronide, tetrahydrocurcumin-glucuronide and tetrahydro-curcumin
as being the major metabolites of curcumin in vivo.
1.7 OBJECTIVES OF THIS STUDY
38
This study was undertaken to investigate the possible role of the Eastern spice
component, curcumin, as a neuroprotectant against oxidative stress in the brain, as well as
damage induced by various neurotoxins. Previous research conducted on curcumin and
Alzheimer’s disease has brought to light statistics that confirm the reduced incidence of
this disease among inhabitants of Indian villages in comparison to the western world
(Ganguli et al., 2000; Lim et al., 2001). This has been attributed to the presence of
several antioxidant and neuroprotective components in various spices commonly
consumed in the daily diet of Indian cultures, one of them being curcumin.
The role of oxidative stress, endogenous toxins like quinolinic acid, mitochondrial
inhibitors like cyanide, and metals like iron, lead and cadmium, in various
neurodegenerative disorders are well established.  The objectives of this study was thus to
observe the effects of curcumin on damage induced by these factors through the
employment of various biological assays as well as inorganic studies. Furthermore, this
study also entailed the elucidation of possible mechanisms by which curcumin may exert
any protective effects against oxidative stress and damage caused by the above mentioned
neurotoxins in the rat brain.
39
CHAPTER TWO
  SUPEROXIDE RADICAL GENERATION
2.1. INTRODUCTION
Reduction of molecular oxygen by the transfer to it of a single electron produces the
superoxide free radical anion also referred to as superoxide (Cheeseman et al., 1993).
O2 + e-                           O2-. (6)
The mitochondrion is the organelle in eukaryotes responsible for aerobic respiration and
is the most common source of ROS during apoptosis. The respiratory chain loses two to
three percent of the electrons during their transfer to molecular oxygen, most of them
participating in the production of superoxide anion (Boveris, 1977). Complex I,
NADH¯ubiquinone oxidoreductase and Complex III, ubiquinol-cytochrome c
oxidoreductase are the two sites in the electron transport chain (ETC) where superoxide
is produced and are diagrammatically represented in Fig. 2.1 (Beyer, 1992). Superoxide
generated by the cycling of ubiquinol in the inner mitochondrial membrane, is produced
primarily in the mitochondrial matrix (Raha et al., 2000).
Superoxide toxicity appears to be through an indirect action on living cells by giving rise
to more powerful oxidants such as the hydroxyl radical. As mentioned in section 1.3.1.6
the dismutation of O2-  generates H2O2 and oxygen, and this reaction is a spontaneous
reaction which can also be catalysed by the enzyme superoxide dismutase.
40
FIG. 2.1 Schematic diagram illustrating the major subunits of the electron
transport chain and sites of O2.- production. Electrons enter the ETC at
either complex I (NADH-ubiquinone oxidoreductase) or complex II
(succinate dehydrogenase) following the oxidation of NADH and
succinate, respectively. Ubiquinone is a lipid-soluble electron carrier and
carries the electrons from complex I and complex II to complex III
(ubiquinol-cytochrome c oxidoreductase). Superoxide (O2.-) can be
produced at both complex I and complex III. It is believed that
semiquinone formation at both complex I and complex III results in the
production of O2.- (Curtin et al., 2002).
The importance of hydrogen peroxide in free radical biochemistry lies in the fact that it
breaks down easily in the presence of transition metal ions to produce the most reactive
and damaging of the oxygen free radicals, the hydroxyl radical (OH.) and this is shown
by equation 5 (section 1.3.2.3). Moreover, as shown in equation 2 (section 1.3.1.6) the
superoxide anion is capable of producing the hydroxyl radical in presence of hydrogen
peroxide (Haber-Weiss reaction). Since these reactions are reversible, there is a constant
generation of superoxide and the promotion of free radical reactions is allowed for.
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In pH environments of approximately 7.4 superoxide partially protonates to form the
hydroperoxyl radical ( HO2. ) a more reactive oxidising species (Rao & Hayon, 1973). In
a study by Antunes et al. (1996) the perhydroxyl radical is estimated to inflict more than
5 times the damage that the hydroxyl radical is capable of.  The protective measures that
the cells employ in response to such damage are usually sufficient except when there is
excessive ROS production, causing the biological defences to be overwhelmed thus
leading to oxidative stress (DiFiglia, 1990).
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2.2. EFFECT OF POTASSIUM CYANIDE ON SUPEROXIDE
RADICAL GENERATION IN RAT BRAIN
HOMOGENATE
2.2.1. INTRODUCTION
Cyanide is a well-established respiratory poison, which exerts its primary toxic effect by
inhibiting cytochrome oxidase, the terminal enzyme of the mitochondrial electron
transport chain (Isom & Way, 1984). The consequence is an impaired tissue utilisation of
oxygen, and with time, oxidative metabolism is brought to a halt. Due to its high
dependence on oxidative metabolism and limited anaerobic capacity, the CNS is
particularly vulnerable to cyanide intoxication (Way, 1984).
The following experiments were conducted to determine the extent of toxicity that
cyanide exerted in rat brain homogenate with respect to the generation of superoxide free
radicals.
2.2.2 MATERIALS AND METHODS
2.2.2.1. Animals
Adult, male, Wistar rats purchased from the South African Institute for Medical Research
(Johannesburg, South Africa) were used throughout the study. The animals weighed
between 250 and 300g and were housed under artificial illumination with a daily
photoperiod of 12 hours. The temperature in the animal house was maintained at 20oC to
24oC with four animals per cage and provided with food and water ad libitum. An
extractor fan ensured the constant removal of stale air.
For the purpose of these experiments, the animals were sacrificed by cervical dislocation
and rapidly decapitated. The brains were surgically removed and either used immediately
or stored at –70 0C.
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2.2.2.2 Chemicals and Reagents
All reagents were of the highest quality available. Potassium cyanide (KCN), nitroblue
tetrazolium (NBT) and nitroblue diformazan (NBD) were purchased from Sigma
Chemical Corporation, St. Louis, U.S.A. Glacial acetic acid was purchased from
Saarchem (PTY) Ltd, Krugersdorp, South Africa. KCN was dissolved in Milli-Q water
for the purposes of the experiment. 0.1% NBT reagent was prepared by dissolving the
NBT in ethanol before making up the solution to the required volume with Milli-Q water.
2.2.2.3 Preparation of the Brain Homogenate
The brains were weighed and rapidly homogenised with 0.01M phosphate buffer saline
(PBS), pH 7.4, so as to give a final concentration of 10% w/v. This is necessary to
prevent lysosomal damage of the tissue.
2.2.2.4 Preparation of Standard Curve
Using NBD as a standard, a series of reaction tubes containing known concentrations of
NBD in glacial acetic acid were prepared. The absorbance of each solution at 20mM
intervals was read at 560 nm and a standard curve was generated (appendix 1).
2.2.2.5 Nitroblue Tetrazolium Assay
The NBT assay is generally accepted as a simple and reliable method for assaying the
superoxide free radical (Ottino and Duncan, 1997).  A modification of the assay used by
Ottino and Duncan (1997) was used in the following set of experiments. Homogenate (1
ml) containing varying concentrations of KCN (0, 0.25, 0.5, 1mM) was incubated with
0.4 ml 0.1% NBT in an oscillating water bath for 1 hour at 37oC. Termination of the
assay and extraction of reduced NBT was carried out by centrifugation of the samples at
2000g and the resuspension of the pellet with 2 ml glacial acetic acid.  The absorbance of
the glacial acetic acid fraction was measured at 560 nm and converted to mmoles
diformazan using a standard curve generated from NBD.
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2.2.3 RESULTS
The final results were corrected for dilutions and expressed as mmoles of diformazan
produced per mg tissue. Potassium cyanide showed a dose-dependent increase in
superoxide radical generation in rat brain homogenate, when compared to the control
(Fig. 2.2). The data represented in these experiments is the mean ± SD of five
determinations. The results were statistically analysed using a one-way analysis of
variance (ANOVA) followed by the Student-Newman-Keuls Multiple Range Test. The
level of significance was accepted at p<0.05 (Zar, 1974).
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FIG. 2.2 Concentration-dependent effect of KCN on superoxide generation in
whole rat brain homogenate. Each bar represents the mean ± SD, n=5; *
(p < 0.05). *** (P < 0.001 in comparison to Control); Student-Newman-
Keuls Multiple Range Test.
2.2.4 DISCUSSION
The results of this study show a concentration-dependent increase in superoxide
formation by potassium cyanide in rat brain homogenate, as compared to the control.
Cyanide is a complex IV inhibitor of the mitochondria. ROS production occurs primarily
within complex I and complex III. A free radical (ubisemiquinone) is normally generated
during the electron transport process, which can potentially donate its unpaired electron
to O2 and generate superoxide. Distal inhibition of the ETC by cyanide augments ROS
production in contrast to proximal site inhibitors such as rotenone or myxothiazol, which
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allows for the ubiquinone pool to become fully oxidised and ROS generation at complex
III is thus nullified (Gregory et al., 2002).
Previous research has also shown cyanide to elevate brain calcium levels (Johnson et al.
1986) and produce an increase in free cytosolic calcium in an isolated neuronal cell
model (Johnson et al. 1987). Elevated calcium levels can lead to activation of numerous
neuronal calcium-dependent events and ultimately results in oxidative stress and free
radical generation. Isolated cerebral and cerebellar mitochondria have been shown to
produce free radicals when exposed to elevated levels of Ca2+ (Dykens 1994). Hence, the
elevation of calcium levels by cyanide in the mitochondria could be another mechanism
by which it induces oxidative stress.
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2.3 EFFECT OF CURCUMIN ON CYANIDE INDUCED
SUPEROXIDE RADICAL GENERATION IN RAT
BRAIN HOMOGENATE
2.3.1 INTRODUCTION
In section 2.2, potassium cyanide showed potent induction of oxidative stress in the form
of superoxide radical generation, in rat brain homogenate. Curcumin has been
demonstrated to have potent antioxidant properties (Kunchandy & Rao, 1990;
Subramanian et al., 1994; Sreejayan, 1994). In this study the ability of curcumin to
effectively scavenge O2-. induced by cyanide in rat brain homogenate was investigated.
2.3.2 MATERIALS AND METHODS
2.3.2.1 In vitro Exposure of Rat Brain to Curcumin
Curcumin was purchased from Sigma Chemical Co., St. Louis, USA and dissolved in a
mixture of ethanol and water in a ratio of 50: 50. The experiments were conducted as
described in section 2.2.2. where brain homogenate was incubated at 370C for one hour,
with the highest concentration of cyanide used previously, alone and in combination with
increasing concentrations of curcumin. Following this, the NBT assay was performed.
2.3.2.2 In vivo Administration of Curcumin
Curcumin was dissolved in ethyl oleate for the purpose of in vivo administration of this
agent to the rat. The rats were divided into two groups each containing six rats. One set of
rats was injected intraperitoneally with 30mg/kg of curcumin twice daily (test group).
The second group of rats was the control group and were injected i.p. with ethyl oleate at
the same time and for the same duration as the test group. The animals were injected for
three consecutive days and on the third day, were sacrificed and brains removed as
described in section 2.2.2.3.
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The experiments were conducted as described in section 2.2.2 and in this case, the
homogenate was allowed to incubate with three concentrations of cyanide at 370C for one
hour, after which the NBT assay was performed.
2.2.3 RESULTS
Curcumin showed a dose-dependent inhibition of superoxide generation induced by 1mM
potassium cyanide in the rat brain homogenate. Curcumin at concentrations of 0.05 and
0.1mM reduced the levels of diformazan to below that of the control with formation after
KCN treatment (Fig. 2.3).
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FIG. 2.3 The effect of curcumin on KCN (1mM)-induced superoxide anion
generation on whole rat brain homogenate. Each bar represents the mean
± SD; n=6.  ** (p < 0.01), *** (p < 0.001); Student-Newman-Keuls
Multiple Range Test.
Brain homogenate obtained from rats that were pre-treated with curcumin 30mg/kg i.p.
for three consecutive days, showed a significant reduction in superoxide generation by
increasing concentrations of potassium cyanide, in comparison to the control (Fig. 2.4).
The data represented in these experiments is the mean ± SD of six determinations. The
results were statistically analysed as described in section 2.2.3.
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FIG. 2.4 The effect of increasing concentrations of KCN on superoxide generation
in rat brain homogenate obtained from rats pretreated with curcumin
30mg/kg i.p. for three consecutive days. Each bar represents the mean ±
SD; n=6.  *** (p < 0.001); Student-Newman-Keuls Multiple Range Test.
2.2.4 DISCUSSION
Curcumin at all concentrations significantly reduced the concentration dependent
induction of superoxide radicals by KCN. Brains obtained from rats that were pre-treated
with curcumin also showed significant protection against cyanide toxicity. The results of
this study clearly show that curcumin is a potent inhibitor of superoxide anions generated
by cyanide in the brain.
Curcumin has gained much interest in current research circles due to its potent anti-
inflammatory and anticancer activities (Srimal, 1987; Ammon et al., 1991). Petrone et al.
(1980) suggests a chemotactic role for superoxide anions in inflammation. Neutrophil
generated superoxide reacts with an extracellular precursor to generate a substance
chemotactic for neutrophils and this appears to play a major role in communication in
neutrophil-mediated inflammatory events. Superoxide dismutase inhibits the appearance
of this chemotactic activity but catalase does not. Prevention of production of this factor
appears to be the major anti-inflammatory action of superoxide dismutase (Petrone et al.,
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1980). Hence it could be postulated that the anti-inflammatory activity of curcumin may
be attributable to its superoxide scavenging properties. Further studies need to be
conducted in this respect.
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CHAPTER THREE
BIOLOGICAL OXIDATION ASSAY
3.1 INTRODUCTION
The primary function of the mitochondrion is to generate adenosine triphosphate (ATP),
the energy currency of the cell. ATP is a ubiquitous store of energy needed for transport
across membranes for all synthetic processes and for the mechanical work involved in
motor activities of the cell (Hammans & Tipton, 1994). Hence energetically
compromised mitochondria may have detrimental effects on the survival of the cell.
Mitochondrial respiratory chain defects have been implicated in the pathogenesis of AD
(Grunewald & Beal, 1999) and mitochondrial dysfunction has been associated with the
neurodegeneration of PD (Berman & Hastings, 1999).
As mentioned earlier, the mitochondria is also an important site of ROS production
particularly the superoxide anions. Oxygen free radicals are natural by-products of
respiration. The electrons formed during the oxidation of glucose are passed along the
electron transport chain and the protons created during electron transfer are used to drive
the synthesis of ATP. A faulty electron transfer at any point in the ETC results in an
electron being accepted by atomic oxygen thus resulting in the creation of a superoxide
free radical (O2.-).
51
3.2           EFFECT OF CYANIDE ON BRAIN
                 MITOCHONDRIAL RESPIRATORY FUNCTION
3.2.1           INTRODUCTION
Cyanide has already been described in chapter two to be a well established respiratory
poison, exerting its toxic effects on the mitochondria by virtue of its inhibition of
complex IV, the cytochrome oxidase enzyme, of the mitochondrial ETC (Isom & Way,
1984). The extent of damage that cyanide causes on rat brain mitochondrial function due
to impaired respiration was investigated using a modification of the biological oxidation
assay described by Plummer (1971).
3.2.2       MATERIALS AND METHODS
3.2.2.1 Animals
Adult, male, Wistar rats, weighing between 250 and 300g were used for the experiment,
and were housed and maintained under the conditions described in section 2.2.2.1.
3.2.2.2 Chemicals and Reagents
All reagents were of the highest quality available. Potassium cyanide (KCN), curcumin,
NAD, 2,6 – diclorophenolindophenol (DPI), and L-Malate were purchased from Sigma
Chemical Corporation, St. Louis, MO, U.S.A. Sucrose was purchased from Saarchem
(PTY) Ltd, Krugersdorp, South Africa. KCN was dissolved in Milli-Q water and
curcumin in 50% ethanol for the purposes of the experiment. All other reagents were
prepared in 0.1M potassium phosphate buffer, pH 7.4.
3.2.2.3 Isolation of Mitochondria from Rat Brain Homogenate
The rats were killed by cervical dislocation, and the brains were rapidly excised and
homogenised with 0.1M potassium phosphate buffer, pH 7.4 to yield a 10% w/v
homogenate.
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Mitochondrial suspensions were prepared by differential centrifugation according to
Plummer (1971). The brain homogenate was centrifuged at 600g for 10 minutes and then
separated into supernatant and pellet. The pellet was resuspended in half the volume of
0.32M sucrose and once again centrifuged at 600g for 10 minutes and the supernatant
obtained was combined with the previous supernatant. The combined supernatant was
centrifuged at 8000g for 10 minutes and the pellet obtained (crude mitochondria) was
washed twice in sucrose and then stored on ice until required.
3.2.2.4 Biological Oxidation Assay
A modification of the spectrophotometric method described by Plummer (1971) was
employed. The rate of reduction of the synthetic electron acceptor dye, 2,6-
dichlorophenol-indophenol (DPI) in presence of the substrate, L-Malate, is used as an
indication of the extent of “activity” of the inner mitochondrial ETC. Homogenate
containing KCN (1mM) was incubated at 370C in a water bath for incubation times of 0,
30 and 60 minutes, after which 1ml of the homogenate was removed and incorporated
with NAD (0.5mM), L-Malate (90 mM), DPI (1.5mM) and potassium phosphate buffer.
The decrease in absorbance over a 5-minute period was read at 1-minute intervals on a
UV/VIS spectrophotometer at 600nm. All data is expressed as absorbance versus time in
minutes and corrected for appropriate controls.
3.2.3 RESULTS
The results obtained demonstrate a progressive decline in mitochondrial ETC activity in
presence of 1mM cyanide, with time. Fig. 3.1 demonstrates the in vitro effect of this
agent on ETC activity in comparison to the control at zero incubation time. A significant
decrease in absorbance is observed after the first two minutes of taking the readings.
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FIG. 3.1 The in vitro effect of cyanide (1mM) on brain
mitochondrial ETC utilising L-Malate as the substrate, after 0 minutes of
incubation time.
Fig. 3.2 shows the effect of cyanide on the ETC activity after 30 minutes of incubation.
In comparison to zero time, there is a decrease in activity of both control and cyanide
treated brain mitochondrial ETC. The decrease in cyanide treated mitochondria can be
observed after the first minute of reading, in contrast to the zero time graph. This can be
attributed to the increased time of contact between the mitochondria and the toxin.
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FIG. 3.2 The in vitro effect of cyanide (1mM) on brain mitochondrial electron
transport, using L-Malate as the substrate, after 30 minutes of incubation
time.
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Fig. 3.3 depicts the in vitro effect of cyanide on brain mitochondrial ETC activity after 60
minutes of incubation. Here again, there is an overall decrease in absorbance for both the
control and cyanide treated mitochondria due to the increased time of incubation. A
significant decrease in the cyanide treated mitochondrial ETC activity, compared to the
control, can be observed just before the 1-minute reading. This drastic change is again
attributable to the increased time of contact between the mitochondria and cyanide.
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FIG. 3.3 The in vitro effect of cyanide (1mM) on brain mitochondrial electron
transport using L-Malate as the substrate, after 60 minutes of incubation
time.
3.2.4 DISCUSSION
The brain is acutely dependent on energy supplies for normal functioning. The
mitochondrion is known to be the intracellular fount of the brain’s energy supplies and
subtle functional alterations in these essential energy dynamos may lead to insidious
pathological changes within neurons (Beal et al., 1993; Beal, 1995). Free radical
reactions as well as mitochondrial inhibitors can decrease the activity of the ETC, which
in turn leads to the obvious impairment in ATP production, and causes the diversion of
electrons from their normal ETC recipients and further formation of damaging free
radicals (Cassarino & Bennett, 1999).
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The present study has shown that cyanide is capable of significantly reducing the activity
of the ETC to levels below that of the control at 0, 30 and 60 minutes of incubation time.
At all time intervals a significant decrease in ETC activity of cyanide treated
mitochondria can be observed after the first 1-2 minutes depending on the time of contact
allowed beween the mitochondria and cyanide. These findings are in accordance with the
fact that cyanide interacts with the haem-a-3 portion of cytochrome oxidase (Slater;
1967), thus preventing oxygen utilisation by the mitochondria, and resulting in
respiratory dysfunction and oxidative stress.
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3.3 EFFECT OF CURCUMIN ON CYANIDE INDUCED
                     IMPAIRMENT OF BRAIN MITOCHONDRIAL
                     RESPIRATORY FUNCTION
3.3.1             INTRODUCTION
Chapter two has shown curcumin to be a potent scavenger of superoxide anions in the
brain homogenate. Since much of the superoxide free radicals originate in the
mitochondria, the following experiment was conducted to assess any effects of curcumin
on the ETC, and whether it was able to offer protection against cyanide induced
impairment of the mitochondrial respiratory functioning.
3.3.2 MATERIALS AND METHODS
3.3.2.1 Animals
Adult, male, Wistar rats, weighing between 250 and 300g were used for the experiment,
and were housed and maintained under the conditions described in section 2.2.2.1.
3.3.2.2 Chemicals and Reagents
Curcumin was purchased from Sigma Chemical Corporation, St. Louis, MO, U.S.A. and
dissolved in 50% ethanol for the experiment.  All other reagents were of the highest
quality available and were purchased and solubilised as described in 3.2.2.2.
3.3.2.3 Isolation of Mitochondria from Rat Brain Homogenate
The brain was excised and homogenised as described in 3.2.2.3. Mitochondrial
suspensions were prepared by differential centrifugation according to Plummer (1971).
3.3.2.3 Biological Oxidation Assay
A modification of the spectrophotometric method described by Plummer (1971) was
employed and was carried out as described in section 3.2.2.4. Homogenate containing
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KCN (1mM) and curcumin (1mM), as well as curcumin (1mM) alone, was incubated at
370C in a water bath for incubation times of 0, 30 and 60 minutes, after which 1ml of the
homogenate was removed and incorporated with NAD (0.5mM), L-Malate (90 mM), DPI
(1.5mM) and potassium phosphate buffer. The decrease in absorbance over a 5-minute
period was read at 1-minute intervals on a UV/VIS spectrophotometer at 600nm.
All data is expressed as absorbance versus time in minutes and corrected for appropriate
controls.
3.3.3 RESULTS
The results obtained show significant protection afforded by curcumin against cyanide
induced brain mitochondrial respiratory dysfunction, with respect to an increase in the
activity of the ETC in presence of curcumin. Fig. 3.4 shows the in vitro effect of
curcumin alone and curcumin in presence of cyanide, on the ETC of brain mitochondria,
in comparison to the control and cyanide treated mitochondria, at 0 incubation time. The
activity of the ETC of curcumin treated mitochondria is significantly higher than that of
the control and cyanide treated mitochondria. The absorbance shows a proportionate
decrease with time.
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FIG. 3.4 A comparison of the in vitro effect of curcumin (1mM) alone and in
                        presence of cyanide (1mM) to that of cyanide (1mM) alone and
                        control, on the brain mitochondrial ETC using L-Malate
                        as the substrate, after 0 minutes of incubation.
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Fig. 3.5 shows the in vitro effect of curcumin alone, and curcumin in presence of cyanide
on the ETC of brain mitochondria, in comparison to the control and cyanide treated
mitochondria, after 30 minutes of incubation. Again curcumin shows significant
protection against cyanide induced decline in ETC activity and this protection lowers
down to the level of the control after the third minute of reading. Mitochondria treated
with curcumin alone shows a significantly higher absorbance reading than all the other
values, indicating that it is capable of increasing the basal levels of activity within the
ETC.
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FIG. 3.5 A comparison of the in vitro effect of curcumin (1mM) alone, in
                        presence of cyanide (1mM), cyanide (1mM) alone and
                        control, on the brain mitochondrial electron transport using L-Malate
                        as the substrate, after 30 minutes of incubation.
Fig. 3.6 depicts the in vitro effect of curcumin alone, and curcumin in presence of
cyanide on the ETC of brain mitochondria, in comparison to the control and cyanide
treated mitochondria, after 60 minutes of incubation. The overall absorbance is decreased
in comparison to the previous two graphs possibly due to the increased time of
incubation. Curcumin shows significant protection and the level of protection decreases
to below levels of the control after around 2.5 minutes of reading. This could be due to
the higher vulnerability of the mitochondria due to the increased time of incubation.
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FIG. 3.6 A comparison of the in vitro effect of curcumin (1mM) alone and in
                        presence of cyanide (1mM) to that of cyanide (1mM) alone and
                        control, on the brain mitochondrial electron transport using L-Malate
                        as the substrate, after 60 minutes of incubation.
3.3.4 DISCUSSION
The extent of intoxication by cyanide on the ETC of brain mitochondria has been
demonstrated and discussed in sections 3.2.3 and 3.2.4. The present results show that
curcumin affords significant protection to the mitochondria against cyanide insult with
respect to the activity of ETC, and this protection has shown to decrease with time. This
however would be expected considering the fact that this experiment is an in vitro one,
and that the vulnerability of the mitochondria is bound to increase with an increase in
time. Curcumin has also shown to increase the basal levels of respiration and ETC
activity within the brain mitochondria.
Previous research has shown curcumin to produce an increase in basal oxygen
consumption of the mitochondria when succinate was used as substrate and a very small
or no effect when pyruvate plus malate was used (Morin et al., 2001). However no data
on the effect of curcumin on the respiratory activity of the mitochondria in presence of
the substrate malate has been shown. The same authors have demonstrated the capability
of curcumin in inducing the mitochondrial permeability transition pore by membrane
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protein thiol oxidation under specified conditions and have postulated that this effect is
the possible mechanism by which it induces apoptosis in tumour cells. This effect
however, has been shown to be independent of the respiratory chain function of the
mitochondria (Morin et al., 2001).
Impaired ETC functioning in the brain leads to cell death via a decrease in ATP
production or an increase in free radical or ROS production (Beal, 1995). The fact that
the major neurodegenerative diseases are age-related may well be accounted for by the
fact that the efficiency of the mitochondrial electron transport decreases with age, and the
production of hydrogen peroxide and superoxide radicals increases with age (Beal, 1995;
Hagen et al., 1997). Curcumin has been shown to potently scavenge superoxide anions in
the previous chapter. By increasing the basal level of respiration in the brain
mitochondrial electron transport chain, and protecting against cyanide induced
impairment of the same, curcumin could serve as a valuable defence system against
mitochondria associated dysfunctions in the body.
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CHAPTER FOUR
LIPID PEROXIDATION
4.1 INTRODUCTION
Biological membranes are known to contain an astonishing variety of lipids, which
satisfy the demands related to membrane structure, fluidity, and permeability (Cullis, et
al., 1991). The oxidative destruction of polyunsaturated fatty acids is termed lipid
peroxidation, and is known to be extremely damaging because of the self–perpetuating
chain reactions they cause (Reiter, et al., 1996).  Extensive lipid peroxidation in
biological membranes results in alterations in fluidity, falls in membrane potential,
increase in permeability to H+ and other ions, and eventual rupture of the cell and its
contents such as the lysosomal hydrolytic enzymes (Halliwell, 1990).
Oxidative stress can be reflected in lipid peroxidation to an extent and the brain and
nervous system is especially prone to such oxidant damage. This is because of its high
levels of unsaturated membrane lipids, which are rich in polyunsaturated fatty acid side
chains, and the presence of transition metals such as iron and copper. These metals are
capable of participating in the Fenton reaction and generating one of the most destructive
of all free radical species, the hydroxyl radical, ultimately resulting in lipid peroxidation.
Moreover the brain has shown high utilisation of oxygen and is relatively deficient in
antioxidant defence mechanisms such as the protective enzymes superoxide dismutase
and catalase (Halliwell, 1990).
4.1.1 Analysis of Lipid Peroxidation by Thiobarbituric Acid Assay
Aldehydes are always produced when lipid hydroperoxides break down in biological
systems (Esterbauer, 1982). Malondialdehyde (MDA) is the most abundant individual
aldehyde resulting from lipid peroxidation and in vitro it has been shown to be capable of
altering proteins, DNA, RNA and other biomolecules (Schaunenstein, 1977). The
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thiobarbituric assay measures the amount of malondialdehyde resulting from the break-
down of lipid hydroperoxides and has served as the most commonly used method for
measuring the extent of lipid peroxidation (Yamamoto, 1990).
In the TBA assay one molecule of MDA reacts with two molecules of TBA to produce a
pink coloured complex having an absorption maximum at 532 – 535nm. The reaction
takes place in acidic conditions (pH of 2 – 3) at 90 to 100oC for one hour. Trichloroacetic
acid (15% w/v) is added to the tissue sample to precipitate protein, which is pelleted by
centrifugation. An aliquot of the supernatant is allowed to react with 0.66% w/v TBA in a
boiling water bath for one hour. Butylated hydroxytoluene in ethanol is added prior to
TCA precipitation to ensure that no lipid oxidation occurs during the assay and interferes
with the results obtained. After cooling the absorbance is read at 532nm and the
concentration of MDA determined from a standard curve generated from 1, 1, 3, 3-
tetramethoxypropane.
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4.2 EFFECT OF QUINOLINIC ACID ON LIPID
PEROXIDATION IN RAT BRAIN HOMOGENATE
4.2.1. INTRODUCTION
Quinolinic acid (2,3-pyridine dicarboxylic acid) is a neurotoxic metabolite of the
tryptophan – kynurenine pathway (Heyes & Morrison, 1997) and is present in the human
and rat brain in nanomolar concentrations (Stone, 1993). Substantial increases in the
concentration of this neurotoxin occur in the body as a consequence of a broad spectrum
of infections and inflammatory neurological diseases. The following experiment was
conducted to investigate the effect of QA on lipid peroxidation in rat brain homogenate.
4.2.2. MATERIALS AND METHODS
4.2.2.1. Animals
Adult, male, Wistar rats, weighing between 250 and 300g were used for the experiment,
and were housed and maintained under the conditions described in section 2.2.2.1.
4.2.2.2. Chemicals and Reagents
1,1,3,3-Tetramethoxypropane (MDA) was obtained from Fluka AG, Switzerland.
Butylated hydroxytoluene (BHT), 2-thiobarbituric acid (TBA) and QA were purchased
from Sigma Chemical Co, St. Louis, USA. Trichloroacetic acid and butanol were
purchased from Saarchem (PTY) Ltd., Krugersdorp, South Africa.
4.2.2.3. Preparation of the Brain Homogenate
The rats were sacrificed by cervical dislocation, and the brains were removed and
homogenised in the same manner described in section 2.2.2.3.
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4.2.2.4. Preparation of Standard Curve
A series of standards (0-20 nmoles/ml) was prepared using 1,1,3,3-tetramethoxypropane
(MDA) and a standard curve generated by measuring the absorbance at 532nm using a
GBC UV/VIS 916 spectrophotometer and plotted against the molar equivalent weight of
MDA in the complex assayed (appendix 2).
4.2.2.5. The TBA Assay
A modification of the method of Ottino & Duncan (1997) was used in this experiment.
Rat brain homogenate was prepared as described earlier and incubated in a shaking water
bath for one hour at 370C with varying concentrations of quinolinic acid to make a final
volume of 1ml.  0.5ml of BHT (0.5g/l ethanol) was added to each tube after incubation,
followed by the addition of 1ml of TCA (10%w/v). The tubes were then centrifuged at
2000rpm for 20 minutes to remove insoluble proteins. 2ml of the supernatant was
transferred to a clean set of tubes and 0.5ml TBA (0.33g/100ml Millipore water) was
added. The tubes were boiled for one hour at 950C, and then cooled on ice. Thereafter the
TBA-MDA complex was extracted with butanol and read at 532nm. MDA levels were
determined from the standard curve generated from 1,1,3,3-tetramethoxypropane.
4.2.3. RESULTS
The final results are expressed as nanomoles of MDA produced per mg tissue. Statistical
analysis was carried out using ANOVA followed by the Student Newman Keuls multiple
range test. The level of significance was accepted at p<0.05. The data represented for
these experiments is the mean ± SD of five determinations (n = 5). The results show a
significant concentration dependent induction in lipid peroxidation by QA with respect to
the control (Fig. 4.1).
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FIG. 4.1 Concentration dependent effect of quinolinic acid on lipid peroxidation in
whole rat brain homogenate. Each bar represents the mean ± SD; n=6.
** (p < 0.01) *** (p<0.001)(Student-Newman-Keuls Multiple Range
Test).
4.2.4. DISCUSSION
Quinolinic acid is an established agonist of the glutamate receptor and previous research
has shown that among a number of glutamate receptor agonists including QA, Kainic
acid, and NMDA, only QA potently induced lipid peroxidation in the rat brain
homogenate (Rios et al., 1991). These findings are consistent with the results obtained in
the present experiment where QA in concentrations of 0.25, 0.5 and 1mM showed
significant induction of lipid peroxidation in the rat brain homogenate in a dose-
dependent manner.
Since QA is not readily metabolised in the synaptic cleft, it stimulates the NMDA
receptor for prolonged periods. This sustained stimulation results in opening of calcium
channels causing Ca2+ influx followed by Ca2+ dependent-enhancement of free radical
production leading to molecular damage and often to cell death (Stone and Perkins,
1981). In the brain homogenate, however, the mechanism by which QA induces oxidative
stress is not well understood. Studies performed by Stipêk et al. (1996) showed that QA
did not induce lipid peroxidation in brain homogenate when co-incubated with an iron-
chelator.
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Spectral analysis revealed that QA was capable of chelating ferrous ions to form a
complex and it was suggested that it is this complex that is responsible for stimulating
lipid peroxidation in the rat brain homogenate. Thus the implication is that QA does not
have a direct peroxidative effect in vitro, but modulates lipid peroxidation through its
interaction with ferrous ions.
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4.3. EFFECT OF CURCUMIN ON QUINOLINIC ACID
INDUCED LIPID PEROXIDATION IN RAT BRAIN
HOMOGENATE
4.3.1. INTRODUCTION
The oxidative damage caused by QA in rat brain homogenate has been demonstrated and
discussed in the section 4.2. The effect of curcumin, a known antioxidant (Kunchandy &
Rao, 1990), on QA induced lipid peroxidation in the rat brain homogenate, was
investigated.
4.3.2           MATERIALS AND METHODS
4.3.2.1. In Vitro Exposure of Rat Brain to Curcumin
The experiments were carried out as described in section 2.2.2. except that only the
highest concentration (1mM) was used, and three sets of tubes containing QA in the
presence of increasing concentrations of curcumin were employed. Curcumin was
purchased from Sigma Chemical Co, St. Louis, USA and dissolved in a mixture of
ethanol and water (50: 50) for the purposes of this experiment.
4.3.2.2. In Vivo Administration of Curcumin
Curcumin was dissolved in ethyl oleate for the purposes of these experiments. The rats
were divided into two groups each containing six rats each. One set of rats was injected
intraperitoneally with 30mg/kg curcumin, twice daily. The other set was injected with
ethyl oleate at the same time and for the same duration as the test rats. The rats were
injected for three days, and on the third day were sacrificed and the brains removed and
homogenised as described in 2.2.2.3. Lipid peroxidation assays were carried out as
described earlier, on these brains, in presence of three concentrations of QA.
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4.3.3. RESULTS
The co-treatment of homogenate with increasing concentrations of curcumin showed a
dose-dependent and significant decrease in lipid peroxidation induced by QA (Fig. 4.2).
Curcumin in concentrations of 0.05 and 0.1mM significantly decreased MDA produced
by the control treated samples.
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FIG. 4.2 The effect of curcumin (in vitro administration) on
QA (1mM)-induced lipid peroxidation in whole rat brain homogenate.
Each bar represents the mean ± SD; n=6; *** (p < 0.001). Student-
Newman-Keuls Multiple Range Test.
With respect to the brains treated with curcumin 30mg/kg in vivo, the test showed a
significant reduction in MDA produced by all three concentrations of QA (Fig. 4.3).
Curcumin administered at this dose also showed a significant inhibition of lipid
peroxidation produced by the control in absence of QA.
***
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FIG. 4.3 The effect of increasing concentrations of QA on MDA levels in rat brain
homogenate obtained from rats treated with 30mg/kg curcumin (i.p.).
Each bar represents the mean±SD (n=5). ** (p<0.01) ***(P<0.001)
Student Newman Keuls Multiple Range Test.
4.3.4. DISCUSSION
The results show clearly that curcumin, administered in vivo and in vitro to the rat brain,
is capable of decreasing QA acid induced lipid peroxidation in a dose-dependent manner,
as well as reducing the lipid peroxidation that occurred in the control samples. Curcumin
is a known antioxidant and free radical scavenger and much of its protective abilities
could be attributed to these properties.
Although the phenolic group and methoxy group are essential for its antioxidant effect,
previous studies conclude that these groups are not essential for curcumin to exert its
inhibiting action on lipid peroxidation in general. Tønnesen & Greenhill (1992) found
that 5-hydroxy-1,7,diphenyl-1,4,6-heptatriene-3-one, a curcumin analog that lacks the
phenolic and methoxy groups, was as active in scavenging hydroxyl radicals and in other
redox properties as curcumin is. A report by Jovanovic et al. (1999) describes the H-atom
donation from the b-diketone moiety to a lipid alkyl or a lipid peroxyl radical as a
potentially more important antioxidant action of curcumin with respect to lipid
peroxidation (Fig. 4.4).
**
***
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FIG. 4.4 H-atom donation of curcumin to a bis-allylic radical (e.g. the linoleic acid
radical (Jovanovic et al., 1999).
The result is the formation of a curcumin radical, with unpaired electron density between
three carbon and two oxygen atoms. If oxygen is added to the central carbon atom, a
peroxyl radical is formed. This is an undesirable reaction because the peroxyl radicals
propagate lipid peroxidation. However it is also possible that the curcumin radicals may
react with each other or with other free radicals to yield stable products such as vanillin,
ferrulic acid and curcumin dimers (Masuda et al., 1999).
Jovanovic et al. (2001) showed that the predominant curcumin radical that is formed is
the phenoxyl radical. Studies performed by these authors state that curcumin, being the
potent lipid-soluble antioxidant that it is, positions itself within the cell membrane, where
it is able to intercept lipid radicals and thereby converts itself into the phenoxyl radical.
This radical is more polar than curcumin so it is capable of moving to the surface of the
membrane, where it may be “repaired” by any water-soluble antioxidant (Fig. 4.5).
71
FIG. 4.5 Diagramatic representation of the antioxidant action of curcumin within
the cell membrane (Jovanovic et al.1999).
The mode of action of QA in inducing lipid peroxidation in rat brain homogenate has
been discussed as one involving a complex formation between QA and ferrous ions. The
possibility that curcumin may be competing with QA for ferrous ion complexation has
been investigated in chapter six and seven.
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4.4. EFFECT OF TOXIC METALS, CADMIUM AND LEAD,
ON LIPID PEROXIDATION IN RAT BRAIN
HOMOGENATE
4.4.1. INTRODUCTION
The brain is known to be a rich depot of metals, both essential and toxic. Lead and
cadmium are two established neurotoxins and the following experiment was aimed at
investigating whether induction of oxidative stress in the form of lipid peroxidation in the
rat brain homogenate, could be a possible mechanism of neurotoxicity.
4.4.2. MATERIALS AND METHODS
Cadmium chloride was dissolved in Milli-Q water to give final concentrations of 0.1,
0.05 and 0.025mM in the brain homogenate. Lipid peroxidation assay was carried out
with cadmium chloride on 10 % w/v rat brain homogenate in the same manner as
described in section 4.2.2.  Lead acetate was solubilised in Milli-Q water to give a final
concentration of 0.01mM in the brain homogenate. Only one concentration of lead
acetate was used and a time-dependent lipid peroxidation assay was carried out on the
brain homogenate by assaying at time intervals of 0, 60, 120 and 180 minutes.
4.4.3. RESULTS
Cadmium chloride in increasing concentrations showed a proportionate and significant
increase in lipid peroxidation when incubated with the rat brain homogenate for 1 hour as
shown in Fig. 4.6. Lead acetate in a concentration of 0.01mM showed significant lipid
peroxidation when compared to the control as shown in Fig. 4.7. As the time of
incubation increased, there was a proportionate and significant increase in lipid
peroxidation.
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FIG. 4.6 The effect of increasing concentrations of cadmium chloride on MDA
production in rat brain homogenate after incubation for 1 hour. Each bar
represents the mean ± SD; n=5. * (p<0.05) *** ( p< 0.001). Student-
Newman-Keuls Multiple Range Test.
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FIG. 4.7 The effect of 0.01mM lead acetate on MDA production in rat brain
homogenate. Each bar represents the mean±SD; n=5. *** ( p< 0.001).
Student-Newman-Keul’s Multiple Range Test.
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4.4.4. DISCUSSION
A dose-dependent induction of MDA was obtained when homogenate was co-treated
with cadmium. Cadmium-induced lipid peroxidation has been extensively studied in
several laboratories but its peroxidative mechanism is a controversial matter, as cadmium
does not undergo redox cycling and probably acts through indirect mechanisms (Casalino
et al., 1997; Yiin et al., 2001).
 Casalino suggested that cadmium displaces iron from its binding sites resulting in iron-
induced lipid peroxidation (Casalino et al., 1997). In vitro experiments showed that
cadmium also displaced and substituted manganese and zinc, resulting in a strongly
reduced MnSOD and CuZnSOD activity and thus proposing a non-specific interaction
between cadmium and superoxide dismutase activity (Hussain et al., 1987, 1999).
The experiments conducted also reveal a significant induction in lipid peroxidation by
lead acetate in the rat brain homogenate, and this was proportionately increased as the
time of incubation increased. In brain homogenate the mode by which lead causes lipid
peroxidation is conjectural. Enhanced lipid peroxidation is associated with stimulation of
arachidonic acid metabolism and prostaglandin formation (Takahashi et al., 1991).
A close association among phospholipid methylation, arachidonic acid release from
phospholipid and increased prostaglandin was found (Crew et al. 1980). Lead is
postulated to be a facilitator of the conversion process of phosphatidylcholine (a major
methylated phospholipid) into arachidonic acid and the metabolite prostaglandin.
Early work on lead toxicity has also established an interaction between iron, zinc and
lead. Lead, zinc and iron are postulated to interact with identical proteins, possibly
transport proteins, which mediate metal uptake (Bressler et al.1999). Lead ions may
directly or indirectly alter the integrity of the membrane by reacting with sulphydryl
groups and lipids and displace Cu2+ (Nakagawa et al., 1980). Rivarov showed that lead is
capable of accelerating lipid peroxidation in the presence of haemoglobin by interaction
with it leading to the production of hydrogen peroxide (Rivarov et al., 1982).
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Lead has also shown to enhance ferrous ion initiated lipid peroxidation in liposomes,
erythrocytes, microsomal fractions and rat brain homogenates (Quinlan et al., 1988,
Oeiza et al., 1995). These observations indicate that lead does cause the degradation of
phospholipids and possibly augments lipid peroxidation caused by other metals such as
iron and copper. This corresponds to the findings of this study, which show a
proportionate rise in lipid peroxidation in the rat brain homogenate with an increase in
time of incubation.
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4.5. EFFECT OF CURCUMIN ON CADMIUM AND LEAD
INDUCED LIPID PEROXIDATION IN RAT BRAIN
HOMOGENATE
4.5.1. INTRODUCTION
Since curcumin was shown to protect the rat brain from lipid peroxidation induced by QA
in section 4.3, the following experiments were conducted to determine whether curcumin
could protect against lipid peroxidative damage induced by toxic metals cadmium and
lead.
4.5.2           MATERIALS AND METHODS
The experimental protocol was carried out as described in section 4.2.2. and the
homogenate was exposed directly to curcumin as described in section 4.2.2.1.
4.5.3            RESULTS
Three increasing concentrations of curcumin were able to significantly decrease MDA
production in the cadmium treated brain homogenate to levels that were lower than the
control. The decline in lipid peroxidation was dose-dependent, with maximum protection
occurring at co-incubation of the homogenate with equimolar concentrations of curcumin
and cadmium as shown in Fig. 4.8.
The steady increase in lipid peroxidation induced by 0.01mM of lead acetate over a time
period of 0 till 180 minutes was significantly reduced in the presence of equimolar
concentrations of curcumin to levels below that of the control (Fig. 4.9).
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FIG. 4.8 The effect of increasing concentrations of curcumin on MDA produced by
0.1mM cadmium in rat brain homogenate. Each bar represents the
mean±SD; n=5. *** (p< 0.001). Student-Newman-Keuls Multiple Range
Test.
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FIG. 4.9. The effect of 0.01mM curcumin on MDA produced by equal
concentrations of lead in rat brain homogenate. Each bar represents the
mean±SD; n=5. *** (p< 0.001). Student-Newman-Keuls Multiple Range
Test.
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4.5.4 DISCUSSION
Cadmium has been shown to produce a dose-dependent increase in lipid peroxidation in
section 4.4.3. and it has been suggested that the mechanism by which this occurs is
through the displacement of iron from its binding sites, resulting in iron-induced lipid
peroxidation, as well as the displacement of the metals crucial to the optimal functioning
of the protective enzyme, superoxide dismutase. Curcumin in increasing doses showed a
proportionate decline in lipid peroxidation induced by 0.1mM cadmium (Fig. 4.8).
Curcumin has been shown to protect against iron-induced lipid peroxidation by forming a
complex with ferric ions (Reddy et al., 1994) and if cadmium is inducing toxicity through
this manner, then it is likely that curcumin is preventing iron-induced lipid peroxidation.
Curcumin being a free radical scavenger, could also be exerting a direct effect on the free
radicals that are being produced. A direct effect of curcumin on cadmium is another
possibility, i.e. the formation of a complex between curcumin and cadmium, thus
preventing cadmium from displacing iron. This has been investigated in chapter six and
seven.
The protective effects of curcumin on lead induced lipid peroxidation (Fig. 4.8) could be
directly attributed to its antioxidant as well as its anti-inflammatory properties. Curcumin
exerts its anti-inflammatory action through the inhibition of the cyclooxygenase pathway,
thereby inhibiting arachidonic acid and prostaglandin synthesis. As mentioned earlier,
lead has been postulated to facilitate the production of arachidonic acid, which is
speculated to be a mode of contribution toward oxidative stress in the form of lipid
peroxidation. Thus curcumin could be reducing lead-induced increase in arachidonic acid
production. The possibility of chelation between lead and curcumin has also been
investigated as another mode of protection by this agent against lead-induced toxicity, in
chapter six and seven.
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CHAPTER 5
HISTOLOGICAL ANALYSIS
5.1 INTRODUCTION
Histology is a term derived from the Greek word histos, meaning tissue, and logia,
meaning “the study of” or knowledge and it involves the examination of preserved,
sectioned and stained tissues of both plants and animals.
Nervous tissues have a wide distribution throughout the body, innervating most visceral
and peripheral tissues. Within the nervous system, there are two basic types of cells,
neurons and supportive cells. Neurons are highly specialised cells that easily conduct
nerve impulses and are easily excited to produce them. Typical neurons as shown in Fig.
5.1 show a large cell body with large central nucleus and many cytoplasmic extensions of
which there are two types: dendrites and axons. These features are also visible on a
stained section of nervous tissue observed under the microscope depicted in Fig. 5.2).
FIG. 5.1 The basic structural features of a neuron (www.wutsamada.com/alma/).
The dendrites are numerous and serve to collect incoming signals either from the
periphery or other neurons, and send them to the cell body. The axon is a long process
that conducts an electrical impulse away from the neuronal cell body to stimulate other
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neurons or tissues. Most neurons have a single axon, although some can have more than
one. Some axons are covered with a sheath of myelin.
FIG. 5.2 A high power magnified section of nervous tissue showing large star
shaped neuronal cell body and the nerve cell processes
(bioweb.uwlax.edu/.../ nervous_tissue__spinal_neuron_.htm).
The supportive cells assist the neuron with its functioning and are found in conjunction
with the neurons. There are various types of supportive cells also known as glial cells:
v Astrocytes: These cells in the brain have a small and round nucleus and many
thin processes radiate from them. The cytoplasm contains intermediate filaments that
are composed of glial fibrillary acidic protein which serves to identify these cells.
v Oligodendroglia: These are small, round cells that are most prominent in the white
matter of the brain. These cells are responsible for myelinating the axons of the
myelinated neurons of the CNS. Myelination of the nerve fibres allows for faster
conduction of nerve impulses. A single oligodendrocyte can provide myelin for as
many as 40 neurons.
v Microglia: These cells are part of the mononuclear phagocyte system of fixed
macrophages in tissues. These are produced in numerous amounts during injury.
1 Nerve Cell Body
2 Nerve Cell
   Processes
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v Schwann cells : These cells are responsible for myelination of the nerve fibres in
the peripheral nervous system.
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5.2 HISTOLOGICAL ANALYSIS OF THE EFFECTS OF
LEAD ON THE HIPPOCAMPUS
5.2.1 INTRODUCTION
The greatest amount of lead found in the brain is localised in the hippocampus,
cerebellum, cerebral cortex, and medulla (Davidson, 1994). Since lead at low doses
damages the functioning of the BBB, it is difficult to analyse whether the distribution of
lead within the CNS reflects the relative vascularisation of different brain regions as
opposed to a specific uptake and distribution process (Goldstein, 1994). The
neuropathological effects of lead on cellular elements of the CNS include cell loss,
haemorrhage and oedema (Goldstein, 1990).
In the present study, the structural effects that lead causes in the hippocampal CA1 and
CA3 regions were examined using histological analysis.
5.2.2 MATERIALS AND METHODS
5.2.2.1 Animals
Adult, male, Wistar rats weighing between 250 and 300g were used for this study and
were cared for as described in section 2.2.2.1. A test group of rats received 25mg/kg of
lead acetate intraperitoneally (i.p), once daily for seven days and control rats received
water in the same manner and for the same duration of time. On the seventh day the rats
were sacrificed and brains removed as described in section 2.2.2.3.
5.2.2.2 Chemicals and Reagents
Lead (II) acetate and cresyl violet stain was purchased from BDH Laboratory Supplies,
England. DPX was purchased from Philip Harris Ltd. England. Haupt’s adhesive
consisted of the following: 1g gelatine, 100ml water, 2g phenol and 15ml glycerol. All
other chemicals used were of the highest quality available and were purchased from
commercial distributors.
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 5.2.2.3 Histological Techniques
5.2.2.3.1 Fixation of the Brain
Neural tissues are extremely fragile and easily subjected to rapid anoxic and postmortem
changes hence immediate fixation of these tissues is required (Chang, 1995). This process
usually entails submerging the tissues in stabilising or cross – linking agents or perfusing
them with these substances in order to preserve as much as possible of their
morphological and molecular characteristics. Here, the brains were immediately and
rapidly fixed in a mixture of formol (30%), glacial acetic acid and ethanol in a ratio of
2:1:7 v/v for two hours.
5.2.2.3.2 Tissue Processing
Moisture was extracted from the tissue fragments by bathing them successively in graded
series of mixtures of ethanol, and this step was followed by the clearing process that
involves the removal of ethanol by immersing the tissue in xylene twice for one hour
each. The tissue was then submerged in molten paraffin wax at 570C twice for one hour
each, which facilitated the removal of xylene and the thorough penetration of the tissue.
This stage provides the hardness and support that the tissue requires for sectioning.
5.2.2.3.3 Blocking Out
This procedure was performed to form a support that would facilitate sectioning using the
rotary microtome. This was done by fixing the brain material into a block using a mould.
A plastic ice tray coated with ethanol- glycine was used as the mould. Molten wax was
added to the mould and allowed to harden. The brain was then removed from the final
molten wax stage and placed carefully onto the mould with warmed forceps. Molten wax
was then poured onto the brain so that it was completely submerged. Air was then gently
blown over the surface of the wax to allow the top to solidify. The entire mould was then
immersed in cold water overnight to facilitate quicker solidification and to prevent the
formation of crystals that might disrupt the tissue.
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5.2.2.3.4 Sectioning
Sectioning is a technique performed using a microtome. This is an instrument, which
consists of a sharp metal knife held in a fixed position, and a chuck in which a block of
wax with the tissue is held. Depending on the type of microtome, a particular mechanism
oscilates the chuck up and down and with each oscillation, the chuck is brought closer to
the knife by a fixed distance. In this way sections are cut from the wax block (Hodgson,
1992).
The wax block was trimmed with a razor blade so that two of the sides were parallel to
each other and the other two sides converged slightly. The sides were cut so as to leave
about 2mm of wax around the tissue. The entire wax block was attached to a small
wooden block with a small amount of wax. A rotary microtome was used to cut ribbons
of sections of 10mm thickness. Once the sections were cut, they were floated on a warm
water bath (400C), which smoothens out the wrinkles.
5.2.2.3.5 Transferring Sections to Slides
The sections were removed from the water bath and placed on a glass microscope slide
using a thin paint brush. The glass slide was initially brushed with a thin layer of Haupt’s
adhesive before the sections were mounted. The slides were left overnight in an oven at
400C to enable the section to adhere to the slide.
5.2.2.3.6       Staining
The sections were Nissl stained using cresyl violet. This stains the Nissl substances
intense purple and the nuclei purple. The background is left clear (Bauer, 1974). Fig. 5.1
shows a Nissl-stained coronal section through the caudal telencephalon of a rat brain
depicting the hippocampus.
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FIG. 5.3 A Nissl-stained coronal section of the caudal telecephalon of a rat brain
showing the hippocampus.
Since this dye is water soluble, the entire embedding process had to be reversed in order
to remove the paraffin wax from the tissue and allow penetration of the dye. The paraffin
was removed by running the slides through xylene twice for five minutes each, followed
by immersion in a mixture of xylene and absolute ethanol (1:1) for three minutes. This
step was followed by immersion in absolute ethanol for five minutes, and then re -
immersion in absolute ethanol overnight.
Sections were stained by placing the slides in 0.1% cresyl violet solution for two hours.
These were then differentiated rapidly by rinsing them in 95% ethanol until the
background was clear. The sections were then dehydrated by processing in absolute
ethanol twice and xylene twice as described in section 5.2.2.3.2 for five minutes each.
5.2.2.3.7 Mounting of Slides
The stained section on the slide must be covered with a thin piece of plastic or glass to
protect the tissue from external damage like scratching, and to provide better optical
quality for viewing under the microscope. While the slides were moist with xylene,
sufficient DPX was added to just cover the tissue. A cover slip was then placed over the
tissue. The slides were allowed to dry over a flat surface for 48 hours.
Hippocampus
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5.2.2.3.8 Photo – microscopy
All the slides were viewed under the light microscope and photographed using a digital
camera.
5.2.3 RESULTS
Neurons in the CA1 and CA3 regions of the hippocampus were examined. Sections of the
CA1 and CA3 regions of the control treated rats (Fig. 5.4 and 5.5 respectively) showed
optimally sized, pyramidally shaped neuronal cells with a clearly observable cell nucleus
and continuous cell membrane. The cells are grouped closely together to form a band –
like appearance, which is characteristic of both the CA1 and CA3 regions.
FIG. 5.4 Cells of the CA1 region of the hippocampus from an animal of the control
group. Magnification x 1000
FIG. 5.5 Cells of the CA3 region of the hippocampus from an animal of the control
group. Magnification x 1000
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The cells of both regions of the lead treated animals (Fig. 5.6 and 5.7) show extensive
violation by virtue of their roundness and swelling. The cells appear scattered with little
integrity of cell membrane and appearance of dense nuclei. Necrosis of the cells in many
areas also appears to have taken place.
FIG. 5.6 Cells of the CA1 region of the hippocampus from an animal treated with
lead acetate (20mg/kg i.p.) for seven days. Magnification x 1000
FIG. 5.7 Cells of the CA3 region of the hippocampus from an animal treated with
lead acetate (20mg/kg i.p.) for seven days. Magnification x 1000
5.2.4 DISCUSSION
Traumatic injury of the brain is characterised by disruption of cell bodies and axons,
followed by little or no axonal regeneration and virtually no recovery of function by the
lesioned tissue. These results clearly demonstrate the structural damage that lead causes
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in the CA1 and CA3 regions of the hippocampus, the part of the brain responsible for
learning and memory processing.
A direct link has been established between low-level, long-term exposure to lead and
deficits in cognitive performance and behaviour in childhood through adolescence. It has
been concluded that no threshold level exists below which lead remains without effect on
the central nervous system (Finkelstein et al., 1998). After the third day of injecting the
rats with lead acetate, visible observations of lead intoxications were demonstrated by
slowness in movement and response as well as relative inactivity of the animals.
Chronic exposure of rats to lead is known to impair the induction of long term potential
(LTP), a component of the hippocampal memory system, in the dentate and the CA1
region of the hippocampus (Gilbert et al., 1996; Zaiser & Miletic, 1997).
One of the mechanisms by which lead induces damage to the brain appears to be through
the inhibition of the myelination process as well as hampering the process of myelin
membrane assembly (Konat, 1984). This explains the complete loss of axons of the cells
of the CA1 and CA3 regions leading to a loss in their pyramidal shape, as shown in Fig.
5.6 and 5.7. In chapter four, it was demonstrated that lead acetate has induced lipid
peroxidation of cell membranes, and this is further supported by the finding that many of
the cells shown in Fig. 5.6 and 5.7 have little integrity of cell membrane or structure.
Reports on the effects of lead on the NMDA receptors have been contradictory,
suggesting activation, inhibition or no change in NMDA receptor activity following lead
exposure (Brook et al., 1993; Guilarte et al., 1994; Jett et al., 1995; Schulte et al., 1995).
However, previous research has postulated lead-calcium interactions to be one of its
molecular mechanisms of toxicity (Bressler et al., 1999). The rise in intracellular levels
of calcium following lead treatment may be due to either lead stimulating calcium entry
or lead inhibiting calcium exit and storage (Zhao et al., 1998). The increased swelling
and necrosis of the cells in the CA1 and CA3 regions may be attributable to increased
intracellular levels of calcium as a direct consequence of lead exposure.
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The observations reported in this experiment demonstrate the hippocampus as an
excellent model for examining the neurotoxic effects of lead and further strengthens the
suggestion that the hippocampus may have a crucial role to play in mediating many of the
behavioural and memory problems associated with lead toxicity.
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5.3 HISTOLOGICAL ANALYSIS OF THE EFFECT OF
                    CURCUMIN ON LEAD – INDUCED STRUCTURAL
                    DAMAGE TO THE HIPPOCAMPUS
5.3.1 INTRODUCTION
Previous experiments show extensive damage caused by exposure to lead in the CA1 and
CA3 regions of the hippocampus of rats (section 5.2). Curcumin has been shown to
afford protection against lead mediated oxidative stress (chapter 4) and the following
experiment was carried out to determine whether curcumin afforded protection against
structural violation of the hippocampus by lead in rats.
5.3.2 MATERIALS AND METHODS
5.3.2.1 Animals
Adult, male, Wistar rats weighing between 250 and 300g were used and cared for as
described in section 2.2.2.1. Test rats were injected with 30mg/kg curcumin
intraperitoneally twice daily and 20mg/kg lead acetate once a day, for seven days. The
animals were injected with curcumin in the morning and evening, and lead acetate at
noon. Both agents were injected on the left and right side respectively, so as to avoid
interaction at the site of administration. Sections obtained from the CA1 and CA3 regions
of these animals were compared to those obtained from the control and lead alone treated
animals
5.3.2.2 Chemicals and Reagents
Chemicals and reagents were obtained as mentioned in section 5.2.2.1. Curcumin was
purchased from Sigma Chemical Co, St. Louis, USA and was solubilised in ethyl oleate
for purposes of administration to the rats.
.
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5.3.2.3 Histological Techniques
These were carried out as described in section 5.2.2.3 and sections were viewed under the
light microscope and photographed using a digital camera.
5.3.3 RESULTS
In comparison to the sections of the CA1 and CA3 regions of the rats treated with lead
only (Fig. 5.6 and 5.7) the neurons of the CA1 and CA3 areas of the lead and curcumin
treated rats (Fig. 5.8 and 5.9) showed significant protection.
FIG. 5.8 Cells of the CA1 region of the hippocampus from an animal treated with
lead acetate (20mg/kg i.p.) and curcumin (30mg/kg i.p.) for seven days.
Magnification x 1000
FIG. 5.9 Cells of the CA3 region of the hippocampus from an animal treated with
lead acetate (20mg/kg i.p.) and curcumin (30mg/kg i.p.) for seven days.
Magnification x 1000
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Many of the cells appear to have retained their pyramidal appearance and are not as
inflamed as those present in the hippocampus of the lead alone treated rats. The cells
show better orientation, integrity of cell membrane and appear closer to each other as
though in an attempt to reconstruct their typical “band-like” appearance.
5.3.4 DISCUSSION
The results of this experiment have shown curcumin to significantly protect against the
structural damage that lead produced in the hippocampus. External observations in the
rats treated with lead and curcumin showed a relatively greater activity and faster
response when compared to those that were treated with lead alone.
The antioxidant activity of curcumin is already well established and its protective action
against lead mediated oxidative stress has already been demonstrated in chapter 4. Since
oxidative stress has been postulated as a possible mechanism of lead mediated toxicity,
curcumin could be scavenging free radicals generated through lead induced calcium
levels in the cell, thus accounting for the reduced swelling in the cells shown in fig. 5.9
and 5.10. Curcumin as an anti-inflammatory agent, could also be playing an important
role in protection.
A third hypothesis is the possible binding of curcumin to this heavy metal, forming a
complex and thus inactivating its toxic effects. This has been investigated in chapter 7.
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CHAPTER SIX
ELECTROCHEMICAL ANALYSIS
6.1 INTRODUCTION
Previous biological work showed curcumin to be capable of protecting against lead and
cadmium induced toxicity in the brain (chapter four and five). The direct interaction and
possible complexation of these heavy metals by curcumin was suggested as a possible
mechanism. Moreover, the protection that curcumin offered against QA and cadmium
induced oxidative insult in the rat brain homogenate (chapter four) were postulated to be
due to an interaction between curcumin and ferric as well as ferrous ions.
Electrochemical analysis was one of the techniques used to probe any such interactions
between curcumin and the metals, lead, cadmium, ferric and ferrous ions.
A chemical reaction in which one or more electrons are transferred from one species to
another is the basis for electrochemical analysis (Pecsok et al., 1968). Electrochemistry
has been used with much success in metal-ligand studies (Limson et al., 1998, Limson &
Nyokong, 2001, Lack & Nyokong, 2001). Limson et al., (1998) used electrochemistry to
show metal-ligand interactions between the pineal hormone melatonin and a range of
metals. In the following experiments two dynamic electroanalytical techniques, cyclic
voltammetry and adsorptive stripping voltammetry were employed to determine whether
curcumin was capable of interacting with lead, cadmium and iron.
The electrochemical cell used in these studies comprises of three electrodes, the working,
reference, and auxiliary electrode as depicted in Fig. 6.1. The first electrode is the
working electrode, where the analyte is oxidised or reduced. Working electrodes of
metallic origin are mostly used. The main requirements of the material considered ideal
for constitution of a working electrode are that it be durable under various solution
conditions, it has a low electrical resistance, and that it has an easily reproducible surface.
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In the studies conducted, the glassy carbon electrode (GCE) was used due to its ideal
surface chemistry for adsorption of analytes. It also possesses excellent mechanical and
electrical properties, is chemically inert and exhibits reproducible performance.
The reference electrode is the standard electrode against which the potential of the
working electrode is referenced. It maintains a constant potential, and is also referred to
as the primary electrode. Commonly used reference electrodes are the hydrogen
electrode, smooth platinum electrode, saturated calomel electrode, silver/silver chloride
electrode, and the glass electrode. The silver/silver chloride electrode was used due to its
suitability in working with aqueous solutions. It consists of a silver wire anodised with
silver chloride in a glass tube, the wire being in direct contact with saturated or
concentrated solutions of AgCl and either KCl or NaCl. The electrode is protected from
the solution by a semi-permeable salt bridge (Sole, 1995, Hawkridge, 1996).
FIG. 6.1 Most dynamic electrochemistry utilizes the classic three-electrode system
as shown here (Limson, 1998).
The third electrode used is called the auxiliary electrode, which is usually constructed of
an inert material such as platinum, and it is used to prevent voltage drop across the
working and reference electrodes. This electrode is not usually isolated from the working
electrode while the reference electrode is (Sole, 1995, Hawkridge, 1996). Current passes
between the working and auxiliary electrode.
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Oxygen is electroactive at almost all electrodes, and seriously interferes with
voltammeric and electrochemical measurements (Sawyer & Roberts, 1974). To remove
the oxygen, nitrogen or any other inert gas is bubbled through the solution.
6.1.1 Cyclic Voltammetry
Cyclic voltammetry (CV) is often the technique of choice for characterising or providing
a fingerprint of electro-active species in solution, mapping the current response produced
at an electrode as a function of potential. During cyclic voltammetry, the electrode
potential is rapidly scanned in search of redox couples. Once located, a couple is
characterised from the potentials of peaks on the cyclic voltammogram and from the
changes caused by variation of the scan rate (Kissinger et al., 1996). The forward scan
generates the oxidised species and the reverse scan, the reduced species (Limson, 1998).
Changes in current response and potential are good indicators of alterations in the
chemistry of a target compound, such as that which occurs during an exchange of
electrons in a metal-ligand bond.
During the redox process the transfer of electrons can be represented by the following
equation:
O refers to the oxidised species, e- the electron and R, the species in reduced form on
acceptance of the electron. Kf and Kr are the formal rate constants for the forward and
reverse reactions, respectively. The conversion of O to R by reduction gives rise to a
cathodic current ic. Oxidation of R to O produces an anodic current, ia. The observed
current resulting in a change of oxidation state is the faradic current, which is a direct
measure of the rate of redox reaction. The resultant current potential plot is the
voltammogram.
RO + ne-
kf
kr
(7)
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FIG. 6.2 A typical cyclic voltammogram (Limson, 1998).
A typical voltammorgram is shown in Fig. 6.2, depicting the ipa, which is the anodic peak
current formed when the electrode oxidises the analyte. The ipc is the cathodic peak
current formed during negative scanning which permits the reduction of the analyte
(Limson, 1998). The cathodic peak potential, Epc, and the anodic peak potential, Epa, can
be read from the voltammograms and the formal reduction potential, E0 of a redox couple
is determined according to the equation below (Wang, 1994; Hawkridge, 1996).
E0’ = (Epa + Epc)/2 (8)
E0’ = formal reduction potential
Epa = anodic peak potential
Epc = cathodic peak potential
6.1.1 Adsorptive Stripping Voltammetry
Adsorptive stripping voltammetry (ASV) exploits the natural tendency of analytes to pre-
concentrate at an electrode and is a useful technique for gauging metal-ligand
interactions.   The electrode is polarised at a more negative potential than the reduction
potential of the metal, and this serves to pre-concentrate the analyte at the electrode.
97
A metal species at an electrode will produce a characteristic response at a specific
potential, with current being proportional to the amount of analyte at the electrode.  When
a suitable ligand is added to a metal solution, the ligand facilitates movement of the metal
to the surface of the electrode. Theoretically then, a ligand which forms a bond with a
metal will bring about a change in the current response observed, as well as a shift in
potential resulting from the reduction of a new species, the metal-ligand complex at the
electrode. The affinity of the ligand toward the metal is expressed by the extent of
increase in current response of the metal on addition of the ligand. A lowering in current
response indicates possible competition by the ligand for binding sites at the electrode at
relatively high analyte concentrations, or formation of strong metal- ligand bonds where
the metal is not easily reduced upon scanning. A negative potential shift indicates a
strong metal-ligand interaction while a large positive shift is associated with a weaker
metal-ligand interaction (Limson et al., 1998; Lack & Nyokong, 2001).
        Accumulation                      Deposition                      Stripping  
   E(V) 
 E(dep) 
 TIME 
  Accumulation Time                 Deposition Time 
 
  M+n + nL ®   MLn+n 
    (9) 
 MLn+n ®   MLn+n,ads 
    (10) 
     MLn+n, ads + e- ®  
                  M+n-1 + nL 
                   (11) 
FIG. 6.3 A diagrammatic representation of the adsorptive stripping voltammetric
technique, showing the accumulation, deposition and stripping steps The
equation numbers are shown in brackets (Limson, 1998).
The steps involved in this technique is diagrammatically explained in Fig. 6.3. To a
solution of metal analyte (M) and electrolyte, a suitable chelating ligand (L) is added and
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metal-ligand complexation (ML) is facilitated. This is the accumulation time during
which the metal-ligand complex has begun to adsorb at the electrode surface by diffusion
from the solution. The electrode potential is held at a fixed deposition potential for a
controlled time (deposition time), while the solution is stirred at a fixed convection rate.
In the stripping step, the adsorbed complex is reduced during a negative going potential
scan and both the metal and ligand are released back into solution.
6.1   MATERIALS AND METHODS
6.2.1 Chemicals and Reagents
Curcumin, lead acetate and cadmium sulphate were purchased from Sigma Chemical
Corporation, St. Louis, U.S.A. Curcumin was dissolved in 50% ethanol-water and the
heavy metals, in Milli-Q water for the electrochemical analysis.  Fresh solutions of
curcumin were prepared daily. Saarchem buffer tablets were used to prepare pH 4 buffer
solutions. Ferric and ferrous solutions were prepared from ferric chloride and ferrous
sulphate salts respectively, both were purchased from Merck, Midrand, South Africa.
6.2.2 Apparatus
Cyclic and stripping voltammograms were obtained with the Bio Analytical Systems
(BAS, Lafayette, Indiana, U.S.A.) CV-50W voltammetric analyzer using a BAS C2 cell
stand to maintain constant atmosphere.  A 3mm diameter glassy carbon electrode (GCE)
was employed as a working electrode for voltammetric experiments.  A silver/silver
chloride [KCl = 3 M] and a platinum wire were employed as reference and auxiliary
electrodes, respectively, in all electrochemical work.  Prior to use, the GCE was cleaned
by polishing with alumina on a Buehler pad, followed by washing in nitric acid and
rinsing in water followed by the buffer solution.  Between scans, the GCE was cleaned by
immersion in a dilute acid solution and rinsed with water.
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6.2.3 Technique
6.2.3.1 Cyclic Voltammetry
For cyclic voltammetric experiments, appropriate concentrations of the metal and ligand
(curcumin) in buffer were introduced into a glass cell and degassed for 5 min with
nitrogen before scanning a potential window.  All potential values quoted are referenced
against the silver/silver chloride reference electrode.
6.2.3.2 Adsorptive Stripping Voltammetry
For adsorptive stripping experiments appropriate concentrations of the metal and of the
ligand (curcumin) were introduced into an electrochemical cell. The solution was then
de-oxygenated with nitrogen for 5 minutes, after which a flow of nitrogen was
maintained over the solution throughout the measurement.  Optimum deposition potential
for each metal was identified and applied for 60 s to effect the formation and adsorption
of the metal and ligand species onto the GCE.
The voltammograms were then scanned in the negative direction from the deposition
potential to at least 0.50V beyond the reduction of the metal at the scan rate of 0.10V s-1
to strip the adsorbed metal-ligand species from the electrode.  During the stripping step,
current responses due to the reduction of the metal-ligand species were measured as a
function of potential.  All potential values quoted are referenced against the silver/silver
chloride (Ag/AgCl) reference electrode.
6.3 RESULTS
6.3.1 CURCUMIN
Fig. 6.4 shows the adsorptive stripping voltammogram for 2.1 x 10-4 M curcumin in pH 4
buffer, with a peak potential of –0.92 V vs Ag/AgCl. The cyclic voltammogram for
curcumin (Fig. 6.5) shows two quasi-reversible oxidation couples: 0.15V with a weak
cathodic return peak [Fig. 6.5 (a)]. The second oxidation is observed at 0.69 V [Fig. 6.5
(b)].
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FIG. 6.4 Adsorptive stripping voltammogram of curcumin in pH 4 buffer.
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FIG. 6.5 Cyclic voltammogram of curcumin in pH 4 buffer.
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6.3.2 CURCUMIN & LEAD
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FIG. 6.6 Adsorptive stripping voltammogram of lead in pH 4 buffer, and
lead in presence of increasing concentrations of curcumin.
Fig. 6.6 (a) shows the ASV of lead (1.2 x 10-4M) in pH 4 buffer at –0.99V vs Ag/AgCl.
In the presence of low concentrations of curcumin, this peak is shifted to negative
potentials of –1.15V. This peak increases with increase in concentration of curcumin and
is attributed to the reduction of the Pb2+-curcumin complex. This is evident in Fig. 6.6 (b
to d), which shows the shifted lead peak in response to increasing concentrations of
curcumin.
At curcumin concentrations at and above (1.3 x 10-4M) a peak at –1.09 V [Fig. 6.7 (a)]
with a new peak observed at –1.38V (*) is observed. The peaks at –1.09V and –1.38V
increased and shifted to more positive potentials with increase in concentration of
curcumin.
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FIG. 6.7 Adsorptive stripping voltammogram of lead alone and in presence of 1.3 x
10-4M curcumin showing a peak at –1.09V as well as the formation of a
new peak (*).
It has been postulated that above equimolar concentrations of Pb2+- curcumin, the Pb2+
peak is not observed while the reduction peak observed at –1.09V is that of a new
species. The peak at –1.38V is also attributed to the reduction of a Pb2+- curcumin
complex, therefore, it is postulated that at these metal- ligand concentrations, two lead-
curcumin species are formed in solution.
6.3.3 CURCUMIN & CADMIUM
Similar electrochemical behaviour was observed for studies of curcumin with Cd2+. Fig.
6.8 (a) shows the ASV for Cd2+ (6 x 10-5M) in pH 4 buffer at –0.82V.  In the presence of
curcumin, (3 x 10-5M) a peak at –1.02V is observed [Fig. 6.8 (b)]. Increasing
concentrations of curcumin increase this peak without any potential shifts [Fig. 6.9 (c –
d)]. It is likely then that this peak is the reduction wave of curcumin.  A new peak (*) as
before is observed at –1.32V for Cd2+ studies in the presence of increasing concentrations
of curcumin. This peak, which has not been observed either for the metal or the ligand
alone and is similar to ASV for Pb2+ with curcumin, has been ascribed to the reduction of
a Cd2+ -curcumin complex.
*
a
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FIG. 6.8 Adsorptive stripping voltammogram of cadmium alone (a) and in presence
of increasing concentrations of curcumin (b, c and d) with the  formation
of a new peak at 10 x 10 -5M curcumin (*).
6.3.4 CURCUMIN & IRON (II)
ASV of Fe2+ (4 x 10-5 M) produces a peak at a potential of  –0.68V [Fig. 6.9 (a)]. In the
presence of 2 x 10-5 M and 6 x 10-5 M curcumin, decreases in current response were
observed with increase in concentration of curcumin. The second peak seen in presence
of curcumin (*) was ascribed to curcumin. No potential shifts were observed.
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FIG. 6.9 ASV of Fe2+ alone (a) and in presence of increasing concentrations of
curcumin. The asterix indicates the curcumin peaks.
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6.3.5 CURCUMIN & IRON (III)
Fig. 6.10 (a) shows the ASV of Fe3+ (4 x 10-5 M) at –0.48V. In the presence of 2 x 10-5M
curcumin [Fig. 6.10 (b)] a decrease in the current response for Fe3+ as well as a slight
shift to less negative potentials is observed.  At higher curcumin concentrations (6 x 10-5
M) the Fe3+ peak disappears as shown in Fig. 6.10 (c) and a new broad peak is observed
at –1.17V (*). This peak is not evident in ASV of curcumin, even at very high
concentrations (2 x 10-4M).
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FIG. 6.10 Adsorptive stripping voltammogram of Fe3+ alone (a) and in presence of
increasing concentrations of curcumin (b and c) with a new peak
formation at 6 x 10-5M curcumin (*).
Curcumin has been shown to form complexes with Fe3+ by cyclic voltammetric methods
(Borsari et al., 2002). It is likely that the disappearance of the Fe3+ peak may be
indicative of a very strong metal-ligand bond, such that the metal is not easily reduced
during the stripping step. The new peak at –1.17V is thus likely to be the reduction of the
Fe3+ - curcumin complex formed.
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6.4 DISCUSSION
The electrochemical data reported above clearly supports the postulation that curcumin
binds to lead and cadmium, forming new complexes and thereby inactivating their toxic
effects. Curcumin has also been shown to strongly bind to Fe3+, thus supporting earlier
studies (Borsari et al., 2002) showing a metal-ligand bond between this metal and
curcumin. Thus it is likely that the chelation of ferric ions is the mechanism involved in
reduction of iron – induced lipid peroxidation (Reddy et al., 1994) and also one of the
mechanisms involved in the reduction of cadmium induced lipid peroxidation, as
discussed in section 3.4.4.
The above studies do not however, support the likelihood of an interaction between
curcumin and Fe2+. This finding does not favour the postulated curcumin-iron interaction
being the mechanism involved in reducing QA-induced lipid peroxidation because QA
binds with ferrous and not ferric ions. In this case it is more likely that curcumin is acting
as a scavenger of free radicals induced by QA and thereby reducing oxidative stress
induced by QA within the membranes.
The highly negative peak observed for curcumin and the metals Pb2+, Cd2+ and Fe3+ at –
1.38V, –1.32V and -1.17V respectively are indicative of strong metal-ligand interactions,
as these reduction potentials are more negative than that of the metal alone. A high
negative potential shift indicates that the species formed between the metal and the ligand
is harder to reduce than the metal alone. Strong metal-ligand bonds are vital for the
efficiency of metal chelators of toxic metals. For Fe3+ and Cd2+ only one species of metal
– curcumin complex was observed in keeping with the smaller ionic radius of these metal
species and thus their ability to bind curcumin in a 1:1 ratio. Pb2+ by comparison has a
larger ionic radius.  The two Pb2+ - curcumin species observed thus corresponds to this
metal species’ ability to bind curcumin at higher ratios.
These results are in keeping with earlier electrochemical studies of the known antioxidant
and free radical scavenger, melatonin (Limson et al., 1998), where weak interactions
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were found between melatonin and essential metals and stronger metal-ligand
interactions with toxic metals such as cadmium and lead.
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CHAPTER SEVEN
METAL BINDING STUDIES - A SPECTROSCOPIC STUDY
7.1 INTRODUCTION
In chapter four it was established that curcumin is capable of protecting the rat brain
against QA, lead and cadmium-induced lipid peroxidation. Curcumin has also been
demonstrated in chapter five to prevent lead-induced structural damage to the rat
hippocampus. The mechanism of action of curcumin has been postulated to involve
metal-binding activity with lead, cadmium and iron, which has been supported by
electrochemical analysis as shown in chapter six. In the following experiments, UV/VIS
and infrared spectroscopic techniques were employed to further establish and characterise
such an interaction between the metals mentioned above and curcumin.
The methods of spectrophotometry are based on the fact that all chemicals, to some
extent, absorb electromagnetic radiations of specific wavelengths. Spectroscopy involves
the technique of measuring the absorption of a beam of light after it passes through a
sample or after reflection from a sample surface.
Ultraviolet and visible spectroscopy involves the energy absorbed by a transition from
one electronic energy level to another. Any species with an extended system of
alternating double and single bonds will absorb UV light, and anything with colour
absorbs visible light, making UV-VIS spectroscopy applicable to a wide range of
samples. Different chemicals may absorb light at different wavelengths so a qualitative
analysis of an unknown chemical may be made by determining the absorption spectrum
of that chemical. Any change in structure or composition of a compound will result in an
electronic change, resulting in a change in the spectrum, either a shift in wavelength or a
change in the extinction coefficient of the absorbance (Newman, 1969).
The principle involved in infrared IR analysis is similar. If absorption is accompanied by
a transition from one vibrational energy level to another, the radiation is from the infrared
portion of the electromagnetic spectrum, and the technique is known as infrared
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spectroscopy, also known as vibrational spectroscopy (Willard et al., 1958). An infrared
(IR) spectrum is generally displayed as a plot of the energy of the IR radiation versus the
percent of light transmitted by the compound. The IR spectrum of a compound is
essentially the superimposition of the absorption bands of specific functional groups, and
even subtle interactions with the surrounding atoms of the molecule affect the spectrum
of the compound (Willard et al., 1958).
7.2 MATERIALS AND METHODS
7.2.1 Chemicals and Reagents
Lead, cadmium, curcumin and potassium bromide were obtained from Sigma Chemical
Corporation, St. Louis, U.S.A. and were prepared as described in section 6.2.2.1. Ferric
and ferrous solutions were prepared from ferric chloride and ferrous sulphate salts
respectively, both were purchased from Merck, Midrand, South Africa. All other
chemicals and reagents were of the highest quality available.
7.2.2 UV/VIS Spectroscopy
The interaction between curcumin and the metal was studied by comparing the absorption
spectra of curcumin alone in solution, and then upon addition of increasing
concentrations of the metal solution. A range of concentrations of equimolar mixtures of
curcumin and metal (2.5 x 10-4 – 3.9 x 10-6 M) were investigated. All the samples were
analysed on a GBC UV/VIS 916 spectrophotometric detector.
7.2.3 Infrared Spectroscopy
A range of solutions of curcumin and metal with metal:ligand ratios between 1:1 and 1:6
were allowed to react. Precipitates obtained were separated, washed, dried, and analysed
by IR using KBr pellets between 4000 and 400cm-1, using a Perkin Elmer 2000 FTIR
spectrometer.
7.3 RESULTS
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7.3.1 UV/VIS Spectroscopy
At 3 x 10-5 M curcumin shows a lamda max of 437nm and upon addition of equal
concentrations of ferric ions, a shift is observed to 429nm with a considerable decrease in
absorbance (Fig. 7.1). This is indicative of metal- ligand complexation.
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FIG. 7.1 Spectroscopic analysis of curcumin and Fe3+ (3 x 10-5 M).
For concentrations of 1.6 x 10-5 M, 7.8 x 10-6 M and 3.9 x 10-6 M, the lamda max of
curcumin remained at 430nm and no shift in the band was observed upon addition of
equal concentrations of ferric ions. However a considerable decrease in the absorbance
was noted (Fig. 7.2). This is also supportive of iron (III)-curcumin chelate formation.
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FIG. 7.2 Spectroscopic analysis of curcumin and Fe3+ (7.8 x 10-6 M).
Similar results were obtained when the interaction of curcumin with ferrous ions, lead
and cadmium were studied spectrophotometrically. This is shown in Figs. 7.3, 7.4, 7.5,
7.6, 7.7, and 7.8.
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FIG. 7.3 Spectroscopic analysis of curcumin and Fe2+ (3 x 10-5 M).
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FIG. 7.4 Spectroscopic analysis of curcumin and Fe2+ (7.8 x 10-6 M).
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FIG. 7.5 Spectroscopic analysis of curcumin and lead (3 x 10-5 M).
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FIG. 7.6 Spectroscopic analysis of curcumin and lead (7.8 x 10-6 M).
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FIG. 7.7 Spectroscopic analysis of curcumin and cadmium (3 x 10-5 M).
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FIG. 7.8 Spectroscopic analysis of curcumin and cadmium (7.8 x 10-6 M).
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At concentrations higher than 3 x 10-5 M, the absorption of curcumin was seen to develop
shoulder bands at 354, 424, 438 and 452nm. Upon addition of equimolar concentrations
of the metal to curcumin solution at a final concentration of 6 x 10-5 M, the split curcumin
peaks collapses to a single peak at 452nm. The splitting of absorbance was retained
however, when metal is added to curcumin at final concentrations of 1.25 x 10-4 M, with
shifts of the bands to lower wavelengths. This behaviour was noted whether a 1cm or
0.2mm cuvette was employed, and is hence clearly a concentration effect rather than a
detector response effect.
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FIG. 7.9 The development of absorption shoulders of curcumin (a, b, c and d) at
concentrations higher than 3 x 10-5 M, and the collapsing thereof into a
single peak upon addition of metal (Fe3+).
7.3.2 Infrared Spectroscopy
The IR spectra showed curcumin (appendix 3) to have a strong sharp O-H stretch at 3541
cm-1, which may be ascribed to the hydroxyl group, and a medium, broad O-H stretch
indicating strong hydrogen bonding at 3514 cm-1, ascribed to the hydrogen-bonded enol
form of the b-diketone moiety. The metal derivatives (appendix 4 and 5) showed two
bands with shifts to lower wavelengths (3430 and 3280 cm-1), both showing strong
hydrogen bonding. This is indicative of metal complexation with both the hydroxyl
groups attached to the two rings and the b-diketone moiety of curcumin.
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Curcumin possesses two strong carbonyls at 1628 and 1603cm-1, and a strong n(C = C) at
1430cm-1 is observed in a rich spectrum between 1400 and 1100cm-1. The infrared
spectra for both the cadmium and lead complexes are identical, suggesting they are
isostructural. Cadmium and lead showed the presence of two carbonyls (1585 and
1528cm-1 for cadmium, and 1586 and 1528 cm-1 for lead) and a shift of n(C = C)
1264cm-1 for both complexes. In addition, several other bands in the infrared spectra are
indicators for complexation.
There is a 10cm-1 shift of the strong curcumin band at 1022cm-1 to higher wave number, a
shift of the medium intensity band of 854cm-1 to 845cm-1 and a collapse of a group of
three weak bands at 574, 562 and 543cm-1 into a single band at 551cm-1 on complexation.
These spectral changes are possibly due to symmetry charges associated with the benzene
rings on complexation.
7.4 DISCUSSION
Curcumin is reported to have an absorption peak at 420 nm, which is ascribed to the
presence of its conjugated diaryl heptanoid chromophore (Matsuda et al., 1999).
However, the results obtained with this study show that at concentrations of 1.6 x 10-5 M
and less, curcumin has a lamda max of 430nm and at concentrations of 3 x 10-5 M, a
lamda max of 437nm. The splitting of the curcumin band at final concentrations higher
than 3 x 10-5 M suggests that curcumin may be forming oligomers at higher
concentrations.
The possibility of curcumin to dimerise has been noted by Matsuda et al. (1999) who
have identified at least two dimeric species with slight shifts of the conjugated diaryl
heptanoid chromophore due to changes in the conjugated system. They have also
identified the radical reaction products vanillin (characteristic absorbance at 238nm) and
ferulic acid (characteristic absorbance at 335nm). In the present study these were
observed in solutions of concentrations greater than 6 x 10-5 M. These results point to the
possibility that at concentrations of 6 x 10-5 M and higher, curcumin is susceptible to
radical degradation under the given conditions.
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At concentrations of 1.6 x 10-5 M and less, the addition of equimolar concentration of
each metal studied caused a decrease in intensity of absorbance but no shift in the
wavelength of the curcumin band. This is indicative of metal-ligand complexation, which
occurs as long as the metal-ligand ratio is not greater than 1: 1 (Tønnesen & Greenhill,
1992).  The shift in the curcumin band upon addition of metal (both at final
concentrations of 3 x 10-5 M) accompanied by a decrease in the absorbance suggests that
the interaction here is different to that of the dimeric species mentioned above.
The results of this study also showed the merging of the split bands of curcumin, upon
addition of equimolar concentrations of metal at a final concentration of 6 x 10-5 M,
which suggests the stabilisation of curcumin on complex formation. Oligomerisation of
the complex appears to be retained at a concentration of 1.25 x 10-4 M, however, due to
the presence of the split bands of curcumin with a shift to lower wavelengths, when metal
was added.
The spectrophotometric data presented in this study clearly implies the direct interaction
between curcumin and the metals, lead, cadmium, Fe2+ and Fe3+. This is in support of the
electrochemical work done with respect to curcumin and the metals, lead, cadmium and
Fe3+ and in contrast to the electrochemical results obtained with curcumin and Fe2+.
Further studies need to be conducted in this respect. The present study also suggests that
a suitable concentration for the therapeutic use of curcumin with regard to its metal –
binding properties is limited to 1.25 x 10-4 M before its degradation products are formed.
The interaction between curcumin and lead, as well as curcumin and cadmium was
further probed by examining the precipitates formed between metal and ligand using
infrared spectroscopic techniques. Curcumin shows two possible sites of interaction with
a metal- the hydroxyl group attached to the two rings and the b-diketone moiety bridging
the two rings. Both sites have been identified as being important to biological activity
(Tønnesen & Greenhill, 1992). The IR results obtained in this study suggest that both
these sites are involved in metal-ligand complexation, either directly bonding to the
metal, or in intermolecular hydrogen bonding.
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Four major forms of metal interaction are known for the b-diketo moiety, which
undergoes keto-enol tautomerism (Nakamoto, 1977). These are diagrammatically
represented in Fig. 7.10.
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FIG. 7.10 Four forms of metal interaction known for the b-diketo moiety
(Nakamotoyo, 1977)
Type A is associated with chelation in the ionic-enolic form. It is characterised by two
strong bands between 1570 – 1525cm-1 and two between 1400 – 1280 cm-1 associated
with the coupled n(C = O) and n(C =C) stretches respectively. Type B is associated with
chelation in the neutral ketonic form. It is characterised by higher wavelengths of the
carbonyls found between 1700 – 1650cm-1. Type C is associated with the neutral enolic
form with only monodentate coordination to the metal. It is characterised by 2 carbonyl
bands at 1630cm-1 (between type A and B) and a lower band at 1560 cm-1. Type D is
associated with the metal binding to the central g-carbon of the ionic ketonic form. It is
characterised by two n(C = O) stretches between 1650 and 1600 cm-1 and two n(C = C)
between 1350-1200 cm-1, lower than that in type A.
The IR data presented above suggests that the metal-ligand binding is in accordance with
type A in the solid state. This is consistent with the results observed for the gallium
complex in solution (Borsai et al., 2002).
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CHAPTER EIGHT
ORGAN CULTURE STUDIES:
THE EFFECT OF CURCUMIN ON RAT PINEAL INDOLE
METABOLISM
8.1 INTRODUCTION
The pineal gland is recognized as an integral and important component of the
neuroendocrine system (Reiter, 1989). The pattern of secretion of its major hormone,
melatonin, conveys information regarding light-dark cycles to the body physiology for
the organization of seasonal and circadian rhythms (Arendt, 1995). This is due to the fact
that the cardinal feature of the melatonin synthesis pathway appears to be its rhythmicity.
Melatonin is a known free radical scavenger and has thus been promoted as an
antioxidant agent with potential roles in protecting against a wide variety of neurological
disorders that stem from ageing and age-related stress, such as AD and PD (Pappolla et
al. 1998). Melatonin is synthesised within the pineal gland itself through the indoleamine
metabolic pathway (Fig. 8.1) and this process can be divided into two parts. The first is
the synthesis of serotonin from tryptophan and the second is the conversion of serotonin
to melatonin and deaminated products.
8.1.1 Synthesis of Serotonin
Tryptophan is hydroxylated to 5-hydroxytryptophan by tryptophan hydroxylase, which is
present in high concentrations in the pineal gland, and this appears to be the rate-limiting
step in the synthesis of serotonin (Lovenberg et al, 1968). However it is the amount of
substrate, tryptophan, available and not the enzyme activity, which influences the rate of
this reaction. (Deguchi et al. 1972; Bensinger et al. 1974). 5-hydroxytryptophan is
dehydroxylated to 5-hydroxytryptamine, also called serotonin, in presence of aromatic-L-
amino acid decarboxylase, which is a nonspecific enzyme found in all tissues, but which
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is present in the pineal organ at high concentrations. (Christenson et al. 1972). The
activity of this enzyme is increased by exposure to constant lighting conditions, and this
increase in activity in response to constant light is mimicked by the removal of the
sympathetic nerves, implying that adrenergic stimulation depresses the activity of this
enzyme. (Synder et al. 1965).
FIG. 8.1 Pineal Indole Metabolism (Young & Silman, 1982).
119
8.1.2 Conversion of Serotonin to its Metabolites
There are two pathways of serotonin metabolism resulting in either deaminated
compounds or N-acetylated compounds. Serotonin may be deaminated by monoamine
oxidase, an enzyme whose activity is known to be particularly high in the pineal gland,
into 5-hydroxyindoleacetylaldehyde. This aldehyde is highly unstable and is immediately
oxidized to the corresponding acid, 5-hydroxyindoleacetic acid, by the enzyme aldehyde
dehydrogenase or reduced to the corresponding alcohol, 5-hydroxytryptophol by alcohol
dehydrogenase (Winters et al., 1977; Morrissey et al., 1978). The 5-hydroxy group
undergoes O-methylation to form corresponding 5-methoxyindoleacetic acid and 5-
methoxytryptophol.
Serotonin may also be N-acetylated to form N-acetyl serotonin and this reaction is
catalyzed by the enzyme N-acetyltransferase (NAT). The activity of the enzyme NAT
increases from 30 fold to 70 fold at night, and is in most circumstances, the rate-limiting
step in melatonin synthesis (Klein et al., 1997). The 5-hydroxygroup of N-acetyl
serotonin is O-methylated in presence of hydroxy-O-methyltransferase to form
melatonin. This enzyme transfers the methyl group from a co-factor, S-adenosyl
methionine to N-acetyl serotonin.
The quantification of pineal indoles and metabolism, and the influence of curcumin on
the pineal indole metabolic pathway and melatonin synthesis were studied using organ
culture. This is a valuable and sensitive technique, which enables the researcher to
manipulate experimental conditions in such a way as to avoid complications of in vivo
interactions. The pineal gland is ideal for organ culture due to its size, and remains viable
for as long as six days under optimum conditions. It is capable of using exogenous
radioactive (14C) serotonin to produce various indoles including melatonin and serotonin
(Daya et al., 1989).
A bi-dimensional thin layer chromatographical system was used to isolate the pineal
indoles (Klein & Notides, 1969). The first solvent comprises of three components
including chloroform: methanol: glacial acetic acid (93:7:1) and it separates melatonin
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(aMT) from N-acetylserotonin (aHT), and the 5-hydroxyindoles from the 5-
methoxyindoles. The second solvent is ethyl acetate, and it separates 5-methoxyindole
acetic acid (MA) and 5-methoxytryptophol (ML) from aMT, as well as 5-hydroxyindole
acetic acid (HA) and 5-hydroxytryptophol (HL) from aHT. Serotonin and 5-
methoxytryptamine are not affected by either of the solvents and remain at the origin
(Anoopkumar-Dukie et al., 2001).
8.2 MATERIALS AND METHODS
8.2.1 Animals
Adult, male, Wistar rats weighing between 250 and 300g were used in this experiment
and were obtained and cared for as described in section 2.2.2.1. The rats were randomly
distributed into two groups, labelled control and test, each group containing five rats. The
rats in the test group were administered with 0.25 ml of curcumin in ethyl oleate
intraperitoneally in a dosage of 30mg/kg daily for three consecutive days, while the
control group received 0.25 ml of ethyl oleate i.p. at the same time for three consecutive
days. Thereafter all the rats were sacrificed by cervical dislocation and rapidly
decapitated.
The brain was exposed in the manner described in section 2.2.2.1, and the pineal organ
was carefully removed. The stalk, and any tissue adhering to the gland were also
removed.
8.2.2 Chemicals and Reagents
14C labelled serotonin was obtained from Amersham International, England. The culture
medium, BGJb culture medium, was purchased from Gibco, Europe, and fortified with
the antibiotics streptomycin and benzyl penicillin (Hoechst, South Africa). The
composition of this medium is represented in the Table 8.1 below. The aluminium TLC
plates coated with silica gel 60, Type F254 (0.25mm), were purchased from Merck,
Darmstadt, Germany. Beckman Ready-Sol multipurpose liquid scintillation fluid was
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purchased from Beckman RIIC Ltd, Scotland. The indole standards, MT, HA, HL, MA,
ML, aMT, and aHT were purchased from Sigma Chemicals Co, St Louis, USA. All other
reagents and chemicals were obtained locally and were of the highest purity available.
CONTENTS CONCENTRATION (mg/litre)
1.6 AMINO ACIDS
L-Alanine 250.0
L-Arginine 175.0
L-Aspartic acid 150.0
L-Cysteine (HCL) 90.0
L-Glutamine 200.0
Glycine 800.0
L-Histidine 150.0
L-Isoleucine 30.0
L-Leucine 50.0
L-Lysine (HCL) 240.0
L-Methionine 50.0
L-Phenylalanine 50.0
L-Proline 400.0
L-Serine 200.0
L-Threonine 75.0
L-Tryptophan 40.0
DL-Valine 65.0
1.7 VITAMINS
a-Tocopherol phosphate 1.0
Ascorbic acid 50.0
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Biotin 0.2
Calcium pantothenate 0.2
Choline chloride 50.0
Folic acid 0.2
Inositol 0.2
Para-aminobenzoic acid 2.0
Pyridoxal phosphate 0.2
Riboflavin 0.2
Thiamine HCl 4.0
Vitamin B12 0.04
1.8 INORGANIC SALTS
Dihydrogen sodium ortho-phosphate 90.0
Magnesium sulphate 200.0
Potassium Chloride 400.0
Potassium dihydrogen phosphate 160.0
Sodium bicarbonate 3500.0
Sodium chloride 5300.0
1.9 OTHER COMPOUNDS
Calcium lactate 555.0
Glucose 10000.0
Phenol red 20.0
Sodium acetate 50.0
Table 8.1 Composition of BGJb culture medium
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8.2.3 Organ culture of the Pineal Glands
The pineal glands were placed individually into sterile borosilicate (75 x 10 mm) Kimble
tubes containing 52ul of BGJb culture medium. 8ul of (14C) serotonin (specific activity
55mCi/mmol) was added. The tubes were then saturated with carbogen (95% Oxygen /
5% Carbon dioxide) and sealed. The tubes were incubated at 37 0C in the dark for 24
hours in a Forma Scientific model 3028 incubator. At the end of the 24-hour incubation
period the reaction was terminated by the removal of the pineal glands from the culture
medium.
8.2.4 Separation of Indoles by Thin Layer Chromatography
A modification of the technique employed by Klein and Notides (1969) was used to
separate the radiolabelled indoles. The TLC plates were activated by placing them in an
oven at 100 0C for 10 minutes. 10ul of the culture medium was spotted on a 10 x 10 cm
thin layer chromatographic (TLC) plate. The spot was dried using a gentle stream of
nitrogen. 10ul of the standard solution was spotted onto the culture medium. The standard
solution was prepared as follows: 0.1mg of each standard indoleamine was dissolved
together in a test tube containing 95% ethanol and 1% ascorbic acid. The ascorbic acid
acts as an antioxidant. The second spot was also dried using a gentle stream of nitrogen.
The spotted plates were placed in a TLC tank containing chloroform: methanol: glacial
acetic acid in a ratio of 93:7:1 and developed twice in this direction. The total front
movement allowed during each development was 9cm and after each development the
plates were dried under a gentle stream of nitrogen. After this, the plates were allowed to
develop once in ethyl acetate at right angles to the first direction of development. The
plates were once again dried under a gentle stream of nitrogen and the spots were
observed and marked under UV light.
The spots were cut out and individually placed in plastic scintillation vials. 1ml of
absolute ethanol was added to each vial, together with 3ml Beckman Ready-Sol
scintillation fluid and then vortexed for 30s. The radioactivity of each metabolite was
then measured in a Beckman LS 2800 scintillation counter.
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8.3 RESULTS
A typical bi-dimensional thin layer chromatogram of the pineal indole metabolites was
obtained which is shown in Fig. 8.2.  Good separation of the indole metabolites and high
counts were obtained. Since serotonin and methoxytryptamine did not migrate from the
origin, the results expressed for the origin are those of methoxytryptamine and serotonin.
The results were obtained as counts per minute (CPM) and each indole metabolite was
expressed in terms of percentage of total counts per minute per 10ul /pineal gland.
 
 Solvent B
Solvent A
FIG. 8.2 An illustration of the bi-dimensional thin layer chromatogram of the
pineal indole metabolites showing the direction in which the plate was run
and the location of the pineal indole metabolites (Klein & Notides, 1969).
Following administration of curcumin (30mg/kg) intraperitoneally, there was an increase
in combined serotonin and 5 – methoxytryptamine levels by 15.5%, N – acetylserotonin
levels by 1.32% and melatonin levels by 0.8% in comparison to the control. A decrease in
5-hydroxyindole acetic acid (6.4%), 5 – hydroxytryptophol (3.9%), 5 – methoxyindole
acetic acid (0.3%) and 5 – methoxytryptophol (0.2%) in comparison to the control, was
also observed (Fig. 8.3).
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All results were analysed using ANOVA followed by the Student-Newman-Keuls
Multiple Range Test. The level of significance was accepted at p<0.05 (Zar, 1974).
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FIG. 8.3 The effect of curcumin on pineal indole metabolism. Each bar represents
the mean ± SD; n = 5. *(p = 0.0001) ** (p = 0.0076).
8.4 DISCUSSION
The increase in radiolabelled - melatonin observed in curcumin treated rats could be
possibly due to improved uptake of radiolabelled – serotonin by the pinealocytes.
Another possibility for the increased levels of radiolabelled serotonin is that curcumin
could be inhibiting monoamine oxidase (MAO) enzyme which is primarily involved in
the conversion of serotonin to its oxidation products. It can be noted that all the
deaminated products of serotonin was found to be decreased in curcumin – treated rats,
with respect to the control. Hence more serotonin is available for the production of
melatonin.
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Mazzio et al. (1998) conducted studies on the effect of various dietary components on
MAO activity in rat C6 glial cells and the results showed a dose – dependent inhibition of
MAO-B activity by curcumin. MAO-B is the predominant form of MAO in human brain.
However serotonin is a specific substrate for MAO-A and further research needs to be
undertaken to determine whether curcumin is capable of specifically inhibiting MAO-A.
The conversion of serotonin to N – acetylserotonin is catalysed by the enzyme serotonin
N – acetyl transferase that is present in the cytoplasm of the cell (Weissbach et al. 1961).
The activity of this enzyme is regulated by an adrenergic cyclic AMP mechanism (Klein
1979). The possibility that curcumin could be increasing N – acetyl serotonin by inducing
this enzyme does not seem likely because Curcumin is a cyclooxygenase – 2 (COX – 2)
inhibitor (Reddy et al. 2002) and this is one of the mechanisms involved in its anti-
inflammatory properties (Huang et al 1991). COX-2 is responsible for the synthesis of
prostaglandin E2 that, on binding to its receptor, induces intracellular cyclic adenosine
monophosphate (cAMP) accumulation (O'Byrne et al. 2000). Inhibition of the COX – 2
pathway and subsequent inhibition of the prostaglandin synthesis results in an inhibition
of cAMP and consequent decrease in N – acetyl transferase. Hence the increase in N –
acetyl serotonin in curcumin treated rats could be more likely attributed to the increased
level of serotonin available as substrate for the enzyme.
N – acetylserotonin is converted to melatonin by hydroxyindole – O – methyl transferase
(HIOMT), which transfers a methyl group from the co – factor S – adenosyl methionine
to the acceptor molecule (Axelrod et al., 1961). The intracellular mechanisms involved in
the regulation of HIOMT have not yet been clearly defined. However it can be postulated
that since there is an increase in N – acetylserotonin, more substrate is available for
HIOMT to produce more melatonin. The direct effect of curcumin on this enzyme is yet
to be investigated.
The increase in melatonin synthesis by curcumin has a direct implication on
neuroprotection based on the ability of melatonin to function as a free radical scavenger
and an antioxidant in the brain. Melatonin has also been shown to protect against
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neuronal cerebral damage induced by acute global cerebral ischemia (Letechipía-Vallejo,
2001) and glial cell survival increased in the presence of melatonin during cerebral
ischaemia (Borlongan, 2000). Although the enhanced production of melatonin and its
precursors by the pineal gland in the presence of curcumin suggests a valuable
mechanism of neuroprotection by curcumin, the experiment conducted demonstrate only
a slight increase of melatonin production (0.8 %) in presence of curcumin. It is thus
debatable as to whether this increase can contribute significantly to neuroprotection or
not.
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CHAPTER NINE
GENERAL CONCLUSIONS AND RECOMMENDATIONS
FOR FUTURE STUDIES
The experiments conducted in this study point conclusively to a new and emerging role
of curcumin as a neuroprotective agent.
The extent of protection that curcumin as an antioxidant, could afford to the brain, against
oxidative stress in the form of superoxide radicals was investigated in chapter two.  The
experimental results indicate that curcumin affords significant protection against cyanide
induced superoxide radical generation in the rat brain homogenate. Brain homogenate
that was obtained from rats pre-injected with curcumin (30mg/kg, i.p.) also showed
significant protection. The superoxide scavenging abilities of curcumin were postulated
to be due to its anti-inflammatory actions.
Since curcumin showed protection to the rat brain homogenate from cyanide induced
superoxide radical generation, and considering the fact that cyanide is a respiratory
poison which acts by blocking complex IV of the ETC, the study in chapter three was
conducted to determine the effect that curcumin had on cyanide induced depression of the
ETC within a mitochondrial fraction isolated from the rat brain. The results demonstrated
an increase in ETC activity in curcumin treated samples compared to cyanide treated
samples. Curcumin also demonstrated an increase in basal level of respiration within the
brain mitochondria. Considering the fact that respiratory inhibition of mitochondria by
cyanide is the basis for its superoxide radical generation, it can be concluded that the
protection offered by curcumin against superoxide radical generation by cyanide was not
only due to its antioxidant properties, but also due to the direct inhibition of cyanide
insult within the ETC.
Chapter four investigated the neuroprotective effects of curcumin against oxidative stress
in the form of lipid peroxidation induced by quinolinic acid, and the toxic metals, lead
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and cadmium. Curcumin significantly reduced lipid peroxidation induced by all three
neurotoxins. Previous work has postulated that the mechanism by which QA induces
lipid peroxidation involves the binding of this toxin to ferrous ions to form a complex,
which then induces peroxidation of the membranes. It is suggested that the protection
curcumin offered to lipid peroxidation induced by QA, lead and cadmium was not only
attributable to the antioxidant properties of this phytochemical, but also due to a possible
chelation of metals, iron (II), iron (III), lead and cadmium.
Histological investigation (chapter five) of nervous tissue within the hippocampal CA1
and CA3 regions showed visible disruptions of the structural features of these regions in
rats treated with lead acetate (25mg/kg i.p.) and significant protection in rats treated
simultaneously with lead acetate (25mg/kg i.p.) and curcumin (30mg/kg i.p.). Moreover
external observations in the rats treated with lead and curcumin showed a relatively
greater activity and faster response as compared to those that were treated with lead
alone. It is suggested that the ability of curcumin to prevent lipid peroxidation induced by
lead could be one of the factors pertaining to the higher degree of integrity of cells within
the hippocampal tissue of the curcumin treated rats. The anti-inflammatory property of
curcumin could also have contributed to the reduced amount of swelling within neuronal
cells in the brains of curcumin treated rats. The possibility that curcumin may be binding
to lead and thus inactivating its neurotoxic effects was also investigated in later chapters.
Chapter six was devoted to the investigation of the metal-binding capabilities of
curcumin with lead, cadmium iron (II) and iron (III), using electrochemical techniques.
The results implied an interaction between curcumin and lead as well as cadmium to form
two new species with lead and one new complex with cadmium. Curcumin also showed
strong interaction with iron (III) with the possibility of a iron (III)-curcumin complex
having been formed in solution. The electrochemical results did not, however, support the
possibility of an interaction with iron (II).
Further analytical work was conducted to probe the interactions between curcumin and
the metals mentioned above, in chapter seven. Solutions of appropriate mixtures of
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curcumin and metal were analysed using UV/VIS spectrophotometric analysis, which
suggested interactions between curcumin and all four metals in terms of a shift in the
wavelength and an increase in absorbance of curcumin. The results of the study also
indicated that the suitable concentration for the therapeutic use of curcumin with regard
to its metal – binding properties is limited to 1.25 x 10-4 M before its degradation
products are produced.
Precipitates formed upon interaction with curcumin and each metal, were also
investigated by spectroscopy, and compared to curcumin alone. Results obtained with
both cadmium and lead – curcumin precipitates, implied the binding of both these metals
by curcumin to form new complexes. Both the hydroxyl groups, and the b-diketone
moiety of curcumin are suggested to be involved in metal-ligand complexation, either
directly bonding to the metal, or in intermolecular hydrogen bonding.
Thus the results of this study strengthens the postulation made earlier suggesting that one
of the mechanisms by which curcumin protects against lead and cadmium toxicity in the
body is by binding to it and forming new complex. This study has also suggested
interaction between curcumin and iron (III) as well as iron (II) but the actual mode of
interaction has not been established. The electrochemical analysis and UV/VIS analysis
showed conflicting results with regards to iron (II)-curcumin interactions, and further
studies need to be conducted in order to clear the ambiguity.
Chapter eight investigated the effect of curcumin on the production of melatonin, a
natural antioxidant and neuroprotectant, produced by the pineal gland. The results
obtained showed that curcumin stimulated an increase in melatonin production. This was
attributed to an increased uptake of serotonin by the pineal gland in the presence of
curcumin and the inhibition of the degradation pathway of serotonin by this
phytochemical. However, the exact mode of action remains to be established. The
increased production of melatonin produced in presence of curcumin appeared to be
minute and hence the neuroprotective capabilities of curcumin may not necessarily be
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attributable to increased production of melatonin, but rather to its antioxidant, anti-
inflammatory and metal-binding capabilities.
No effective cure has so far been reported to treat neurological disorders associated with
aging other than therapeutic interventions that could forestall or delay the normal and
pathological ageing process. With respect to such a prophylactic approach, nutritional
interventions may be viewed as a viable option (Deschamps et al., 2001; Youdim &
Joseph, 2001). Curcumin, the principle component of a daily dietary component of the
Asian population, has been shown to afford protection to the brain against cyanide,
quinolinic acid, lead and cadmium induced insult in vitro and in vivo. This study has also
shown that the antioxidant and anti-inflammatory activities of curcumin contribute
toward its neuroprotective abilities. Moreover the metal binding capabilities of curcumin
with lead, cadmium and iron, have implications on neuroprotection because of the extent
of involvement of metals with the brain with respect to oxidative stress and
neurodegeneration.
Although the results of this study point to a possible role of curcumin as neuroprotectant,
further research on this polyphenolic compound needs to be conducted in order to
confirm the deductions made. The metal-chelating property of curcumin with lead and
cadmium as demonstrated in this study, is an exciting prospect which also needs to be
analysed in depth as to the characterisation of the new complexes formed, its biological
and toxicological properties, as well as pharmacokinetic properties. The structure and
properties of the flavonoids predict that they have a good chance of reaching and
mobilising heavy metals within the body as well as form strong ligand complexes with
heavy metal ions (Havsteen, 2002). Hence, the interactions of curcumin with a wider
range of metals can be analysed, along with its effects on the biological damages that
such metals produce in the body.
It would also be worthwhile investigating the consequences of the long-term use of
curcumin especially with regard to its metal-chelating properties. This is of high
significance with metals like iron and zinc, which are essential to various functions in the
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body. Depletion of these metals lead to various disease conditions. Iron deficiency not
only leads to anaemia, but can also lead to adverse effects on the cells of the CNS and on
neurotransmitters. Iron-deficiency anaemia can also lead to reduced oxygen delivery to
the brain (Gordon, 2003).
Another area for future study would be an investigation into the molecular mechanisms
by which curcumin exerts its various neuroprotective abilities. The possibility that
curcumin could be regulating a number of heat shock responses, a universally
fundamental mechanism necessary for cell survival under a variety of unfavourable
conditions, has already been raised, and such studies need to be facilitated in order to
determine the exact mode of action of curcumin. The effects of curcumin on various
receptors on the brain, such as those involved in excitotoxicity, also needs to be explored.
While pharmaceutical companies continue to invest huge resources into identifying
agents which could be used to alleviate debilitating neurodegenerative diseases, a source
of potentially beneficial agents, namely phytochemicals, appears to offer significant
benefits that are yet to be fully exploited. Interventions at an early stage of neurological
diseases is an important step in combating the illness, since by the time the symptoms of
such disorders occur, a certain amount of neuronal death has already occurred. In this
light, it is interesting to note that some epidemiological studies have shown that dietary
habits can influence the incidence of neurodegenerative disorders (Esposito, 2002).
Thus, it is desirable and of benefit, that more studies on the potential benefits of curcumin
as a neuroprotectant and metal-chelator be conducted, as well as investigations into the
relationship between curcumin and the relative risk for the development of various
neurodegenerative disorders such as AD and PD be facilitated.
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APPENDIX 1  CALIBRATION CURVE FOR DIFORMAZAN (R2 = 0.999)
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APPENDIX 2 MALONDIALDEHYDE STANDARD CURVE (R2 = 0.999)
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APPENDIX 3 INFRARED SPECTROSCOPY OF CURCUMIN
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APPENDIX 4 INFRARED SPECTROSCOPY OF ISOLATED CURCUMIN-
LEAD COMPLEX
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APPENDIX 5 INFRARED SPECTROSCOPY OF THE ISOLATED
CURCUiroMIN – CADMIUM COMPLEX
